-
3
-
-
0038283161
-
Interleukin-10 therapy - Review of a new approach
-
ASADULLAH K, STERRY W, VOLK HD: Interleukin-10 therapy - review of a new approach. Pharmacol. Rev. (2003) 55:241-269.
-
(2003)
Pharmacol. Rev.
, vol.55
, pp. 241-269
-
-
Asadullah, K.1
Sterry, W.2
Volk, H.D.3
-
4
-
-
0035252656
-
Hijacking and exploitation of IL-10 by intracellular pathogens
-
REDPATH S, GHAZAL P, GASCOIGNE NR: Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol. (2001) 9:86-92.
-
(2001)
Trends Microbiol.
, vol.9
, pp. 86-92
-
-
Redpath, S.1
Ghazal, P.2
Gascoigne, N.R.3
-
5
-
-
0038631849
-
Type 1 T-regulatory cells: Their role in the control of immune responses
-
GROUX H: Type 1 T-regulatory cells: their role in the control of immune responses. Transplantation (2003) 75:8S-12S.
-
(2003)
Transplantation
, vol.75
-
-
Groux, H.1
-
6
-
-
0038617550
-
The role of interleukin-10 in the control of autoimmunity
-
RONCAROLO MG, BATTAGLIA M, GREGORI S: The role of interleukin-10 in the control of autoimmunity. J. Autoimmun. (2003) 20:269-272.
-
(2003)
J. Autoimmun.
, vol.20
, pp. 269-272
-
-
Roncarolo, M.G.1
Battaglia, M.2
Gregori, S.3
-
7
-
-
0035992506
-
The family of IL-10-related cytokines and their receptors: Related, but to what extent?
-
KOTENKO SV: The family of IL-10-related cytokines and their receptors: related, but to what extent? Cytokine Growth Factor Rev. (2002) 13:223-240.
-
(2002)
Cytokine Growth Factor Rev.
, vol.13
, pp. 223-240
-
-
Kotenko, S.V.1
-
8
-
-
0034897552
-
Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site
-
JOSEPHSON K, LOGSDON NJ, WALTER MR: Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site. Immunity (2001) 15:35-46.
-
(2001)
Immunity
, vol.15
, pp. 35-46
-
-
Josephson, K.1
Logsdon, N.J.2
Walter, M.R.3
-
9
-
-
0036694663
-
Regulation of cytokine signaling and inflammation
-
HANADA T, YOSHIMURA A: Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. (2002) 13:413-421.
-
(2002)
Cytokine Growth Factor Rev.
, vol.13
, pp. 413-421
-
-
Hanada, T.1
Yoshimura, A.2
-
10
-
-
0033104615
-
Selective regulation of cytokine induction by adenoviral gene transfer of IκBα into human macrophages: Lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-κB independent
-
BONDESON J, BROWNE KA, BRENNAN FM, FOXWELL BM, FELDMANN M: Selective regulation of cytokine induction by adenoviral gene transfer of IκBα into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-κB independent. J. Immunol. (1999) 162:2939-2945.
-
(1999)
J. Immunol.
, vol.162
, pp. 2939-2945
-
-
Bondeson, J.1
Browne, K.A.2
Brennan, F.M.3
Foxwell, B.M.4
Feldmann, M.5
-
11
-
-
0037201722
-
Regulation of the activity of Sp1-related transcription factors
-
BOUWMAN P, PHILIPSEN S: Regulation of the activity of Sp1-related transcription factors. Mol. Cell. Endocrinol. (2002) 195:27-38.
-
(2002)
Mol. Cell. Endocrinol.
, vol.195
, pp. 27-38
-
-
Bouwman, P.1
Philipsen, S.2
-
12
-
-
0034651850
-
A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages
-
BRIGHTBILL HD, PLEVY SE, MODLIN RL, SMALE S: A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J. Immunol. (2000) 164:1940-1951.
-
(2000)
J. Immunol.
, vol.164
, pp. 1940-1951
-
-
Brightbill, H.D.1
Plevy, S.E.2
Modlin, R.L.3
Smale, S.4
-
13
-
-
0035958007
-
The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages
-
MA W, LIM W, GEE K et al.: The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. (2001) 276:13664-13674.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 13664-13674
-
-
Ma, W.1
Lim, W.2
Gee, K.3
-
14
-
-
0037769043
-
Functional cooperation of simian virus 40 promoter factor 1 and CCAAT/enhancer-binding protein β and δ in lipopolysaccharide-induced gene activation of IL-10 in mouse macrophages
-
LIU YW, TSENG HP, CHEN LC, CHEN BK, CHANG WC: Functional cooperation of simian virus 40 promoter factor 1 and CCAAT/enhancer-binding protein β and δ in lipopolysaccharide-induced gene activation of IL-10 in mouse macrophages. J. Immunol. (2003) 171:821-828.
-
(2003)
J. Immunol.
, vol.171
, pp. 821-828
-
-
Liu, Y.W.1
Tseng, H.P.2
Chen, L.C.3
Chen, B.K.4
Chang, W.C.5
-
15
-
-
0031985903
-
Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-α: Role of the p38 and p42/44 mitogen-activated protein kinases
-
FOEY AD, PARRY SL, WILLIAMS LM et al.: Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-α: role of the p38 and p42/44 mitogen-activated protein kinases. J. Immunol. (1998) 160:920-928.
-
(1998)
J. Immunol.
, vol.160
, pp. 920-928
-
-
Foey, A.D.1
Parry, S.L.2
Williams, L.M.3
-
16
-
-
0037090078
-
Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia
-
BRANGER J, VAN DEN BLINK B, WEIJER S et al.: Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. J. Immunol. (2002) 168:4070-4077.
-
(2002)
J. Immunol.
, vol.168
, pp. 4070-4077
-
-
Branger, J.1
Van Den Blink, B.2
Weijer, S.3
-
17
-
-
0037929186
-
Defining the involvement of p38α MAP kinase in the production of anti- and pro-inflammatory cytokines using an SB-203580-resistant form of the kinase
-
GUO X, GERL RE, SCHRADER JW: Defining the involvement of p38α MAP kinase in the production of anti- and pro-inflammatory cytokines using an SB-203580-resistant form of the kinase. J. Biol. Chem. (2003) 278:22237-22242.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 22237-22242
-
-
Guo, X.1
Gerl, R.E.2
Schrader, J.W.3
-
18
-
-
0038661170
-
PLIF induces IL-10 production in monocytes: A calmodulin-p38 mitogen-activated protein kinase-dependent pathway
-
ZAHALKA MA, BARAK V, TRAUB L, MOROZ C: PLIF induces IL-10 production in monocytes: a calmodulin-p38 mitogen-activated protein kinase-dependent pathway. FASEB J. (2003) 17:955-957.
-
(2003)
FASEB J.
, vol.17
, pp. 955-957
-
-
Zahalka, M.A.1
Barak, V.2
Traub, L.3
Moroz, C.4
-
19
-
-
0034254225
-
Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression
-
BENKHART EM, SIEDLAR M, WEDEL A, WERNER T, ZIEGLER-HEITBROCK HW: Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression. J Immunol. (2000) 165:1612-1617.
-
(2000)
J. Immunol.
, vol.165
, pp. 1612-1617
-
-
Benkhart, E.M.1
Siedlar, M.2
Wedel, A.3
Werner, T.4
Ziegler-Heitbrock, H.W.5
-
20
-
-
0043033208
-
Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophages
-
OKUGAWA S, OTA Y, KITAZAWA T et al.: Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophages. Am. J. Physiol. Cell Physiol. (2003) 285:C399-C408.
-
(2003)
Am. J. Physiol. Cell Physiol.
, vol.285
-
-
Okugawa, S.1
Ota, Y.2
Kitazawa, T.3
-
21
-
-
0038544646
-
IFN-α induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3
-
ZIEGLER-HEITBROCK L, LOTZERICH M, SCHAEFER A et al.: IFN-α induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3. J. Immunol. (2003) 171:285-290.
-
(2003)
J. Immunol.
, vol.171
, pp. 285-290
-
-
Ziegler-Heitbrock, L.1
Lotzerich, M.2
Schaefer, A.3
-
23
-
-
0035115080
-
Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages
-
HIRSCHFELD M, WEIS JJ, TOSHCHAKOV V et al.: Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. (2001) 69:1477-1482.
-
(2001)
Infect. Immun.
, vol.69
, pp. 1477-1482
-
-
Hirschfeld, M.1
Weis, J.J.2
Toshchakov, V.3
-
24
-
-
0037152173
-
Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression
-
SING A, ROST D, TVARDOVSKAIA N et al.: Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med. (2002) 196:1017-1024.
-
(2002)
J. Exp. Med.
, vol.196
, pp. 1017-1024
-
-
Sing, A.1
Rost, D.2
Tvardovskaia, N.3
-
25
-
-
0038446051
-
Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide
-
MARTIN M, SCHIFFERLE RE, CUESTA N et al.: Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J. Immunol. (2003) 171:717-725.
-
(2003)
J. Immunol.
, vol.171
, pp. 717-725
-
-
Martin, M.1
Schifferle, R.E.2
Cuesta, N.3
-
26
-
-
0042854698
-
TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection
-
MUN HS, AOSAI F, NOROSE K et al.: TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int. Immunol. (2003)15:1081-1087.
-
(2003)
Int. Immunol.
, vol.15
, pp. 1081-1087
-
-
Mun, H.S.1
Aosai, F.2
Norose, K.3
-
27
-
-
0033777841
-
Catecholamines induce IL-10 release in patients suffering from acute myocardial infarction by transactivating its promoter in monocytic but not in T cells
-
RIESE U, BRENNER S, DOCKE WD et al.: Catecholamines induce IL-10 release in patients suffering from acute myocardial infarction by transactivating its promoter in monocytic but not in T cells. Mol. Cell. Biochem. (2000) 212:45-50.
-
(2000)
Mol. Cell. Biochem.
, vol.212
, pp. 45-50
-
-
Riese, U.1
Brenner, S.2
Docke, W.D.3
-
28
-
-
0037458585
-
cAMP-induced interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation
-
BRENNER S, PROSCH S, SCHENKE-LAYLAND K et al.: cAMP-induced interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation. J. Biol. Chem. (2003) 278:5597-5604.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 5597-5604
-
-
Brenner, S.1
Prosch, S.2
Schenke-Layland, K.3
-
29
-
-
17044447324
-
Regulation of TNFα and interleukin-10 production by prostaglandins I(2) and E(2): Studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists
-
SHINOMIYA S, NARABA H, UENO A et al.: Regulation of TNFα and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists. Biochem. Pharmacol. (2001) 61:1153-1160.
-
(2001)
Biochem. Pharmacol.
, vol.61
, pp. 1153-1160
-
-
Shinomiya, S.1
Naraba, H.2
Ueno, A.3
-
31
-
-
0036737053
-
Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: Dual effect on IL-12 and stimulation of IL-10
-
WILKIN F, STORDEUR P, GOLDMAN M, BOEYNAEMS JM, ROBAYE B: Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10. Eur. J. Immunol. (2002) 32:2409-2417.
-
(2002)
Eur. J. Immunol.
, vol.32
, pp. 2409-2417
-
-
Wilkin, F.1
Stordeur, P.2
Goldman, M.3
Boeynaems, J.M.4
Robaye, B.5
-
32
-
-
0038586297
-
S-adenosylmethionine (AdoMet) modulates endotoxin stimulated interleukin-10 production in monocytes
-
SONG Z, BARVE S, CHEN T et al.: S-adenosylmethionine (AdoMet) modulates endotoxin stimulated interleukin-10 production in monocytes. Am. J. Physiol. Gastrointest. Liver Physiol. (2003) 284:G949-G955.
-
(2003)
Am. J. Physiol. Gastrointest. Liver Physiol.
, vol.284
-
-
Song, Z.1
Barve, S.2
Chen, T.3
-
33
-
-
0037360309
-
Regulation of dendritic cell function by microbial stimuli
-
REIS E SOUSA C, DIEBOLD SD, EDWARDS AD et al.: Regulation of dendritic cell function by microbial stimuli. Pathol. Biol. (2003) 51:67-68.
-
(2003)
Pathol. Biol.
, vol.51
, pp. 67-68
-
-
Reis, E.1
Sousa, C.2
Diebold, S.D.3
Edwards, A.D.4
-
34
-
-
2242487380
-
A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization
-
VAN DER KLEIJ D, LATZ E, BROUWERS JF et al.: A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J. Biol. Chem. (2002) 277:48122-48129.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 48122-48129
-
-
Van, D.E.R.1
Kleij, D.2
Latz, E.3
Brouwers, J.F.4
-
35
-
-
0037767231
-
Differential induction of interleukin-10 and interleukin-12 in dendritic cells by microbial toll-like receptor activators and skewing of T-cell cytokine profiles
-
QI H, DENNING TL, SOONG L: Differential induction of interleukin-10 and interleukin-12 in dendritic cells by microbial toll-like receptor activators and skewing of T-cell cytokine profiles. Infect. Immun. (2003) 71:3337-3342.
-
(2003)
Infect. Immun.
, vol.71
, pp. 3337-3342
-
-
Qi, H.1
Denning, T.L.2
Soong, L.3
-
36
-
-
0242642475
-
Functional defects of dendritic cells in CD40-deficient patients
-
[Electronically published ahead of print.]
-
FONTANA S, MORATTO D, MANGAL S et al.: Functional defects of dendritic cells in CD40-deficient patients. Blood (2003). [Electronically published ahead of print.]
-
(2003)
Blood
-
-
Fontana, S.1
Moratto, D.2
Mangal, S.3
-
38
-
-
0038603203
-
Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells
-
PANTHER E, CORINTI S, IDZKO M et al.: Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood (2003) 101:3985-3990.
-
(2003)
Blood
, vol.101
, pp. 3985-3990
-
-
Panther, E.1
Corinti, S.2
Idzko, M.3
-
39
-
-
0042430426
-
Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation
-
LAVELLE EC, MCNEELA E, ARMSTRONG ME et al.: Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J. Immunol. (2003) 171:2384-2392.
-
(2003)
J. Immunol.
, vol.171
, pp. 2384-2392
-
-
Lavelle, E.C.1
Mcneela, E.2
Armstrong, M.E.3
-
41
-
-
0033558986
-
A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: Dependence on CD28 signaling and preferential inhibition of IL-10 production
-
KOPRAK S, STARUCH MJ, DUMONT FJ: A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: dependence on CD28 signaling and preferential inhibition of IL-10 production. Cell. Immunol. (1999) 192:87-95.
-
(1999)
Cell Immunol.
, vol.192
, pp. 87-95
-
-
Koprak, S.1
Staruch, M.J.2
Dumont, F.J.3
-
42
-
-
0242586146
-
Mechanisms of H4/ICOS costimulation: Effects on proximal TCR signals and MAP kinase pathways
-
FEITO MJ, VASCHETTO R, CRIADO G et al.: Mechanisms of H4/ICOS costimulation: effects on proximal TCR signals and MAP kinase pathways. Eur. J. Immunol. (2003) 33:204-214.
-
(2003)
Eur. J. Immunol.
, vol.33
, pp. 204-214
-
-
Feito, M.J.1
Vaschetto, R.2
Criado, G.3
-
43
-
-
0035121969
-
Regulation of the IL-10 production by human T cells
-
RAFIQ K, CHARITIDOU L, BULLENS DM et al.: Regulation of the IL-10 production by human T cells. Scand. J. Immunol. (2001) 53:139-147.
-
(2001)
Scand. J. Immunol.
, vol.53
, pp. 139-147
-
-
Rafiq, K.1
Charitidou, L.2
Bullens, D.M.3
-
44
-
-
0038527380
-
Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency - Involvement of protein kinase A Type I
-
HOLM AM, AUKRUST P, AANDAHL EM et al.: Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency - involvement of protein kinase A Type I. J. Immunol. (2003) 170:5772-5777.
-
(2003)
J. Immunol.
, vol.170
, pp. 5772-5777
-
-
Holm, A.M.1
Aukrust, P.2
Aandahl, E.M.3
-
45
-
-
0032521266
-
Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production
-
DUMONT FJ, STARUCH MJ, FISCHER P, DASILVA C, CAMACHO R: Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J. Immunol. (1998) 160:2579-2589.
-
(1998)
J. Immunol.
, vol.160
, pp. 2579-2589
-
-
Dumont, F.J.1
Staruch, M.J.2
Fischer, P.3
Dasilva, C.4
Camacho, R.5
-
46
-
-
0041777783
-
BiP, a putative autoantigen in rheumatoid arthritis, stimulates IL-10-producing CD8-positive T cells from normal individuals
-
BODMAN-SMITH MD, CORRIGALL VM, KEMENY DM, PANAYI GS: BiP, a putative autoantigen in rheumatoid arthritis, stimulates IL-10-producing CD8-positive T cells from normal individuals. Rheumatology (2003) 42:637-644.
-
(2003)
Rheumatology
, vol.42
, pp. 637-644
-
-
Bodman-Smith, M.D.1
Corrigall, V.M.2
Kemeny, D.M.3
Panayi, G.S.4
-
47
-
-
0034887225
-
Anti-inflammatory effects of chemically modified tetracyclines by the inhibition of nitric oxide and interleukin-12 synthesis in J774 cell line
-
DAGOSTINO P, FERLAZZO V, MILANO S et al.: Anti-inflammatory effects of chemically modified tetracyclines by the inhibition of nitric oxide and interleukin-12 synthesis in J774 cell line. Int. Immunopharmacol. (2001) 1:1765-1776.
-
(2001)
Int. Immunopharmacol.
, vol.1
, pp. 1765-1776
-
-
Dagostino, P.1
Ferlazzo, V.2
Milano, S.3
-
48
-
-
0036045743
-
Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: A comparison of 6 chemically modified tetracyclines
-
RAMAMURTHY NS, RIFKIN BR, GREENWALD RA et al.: Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines. J. Periodontol. (2002) 73:726-734.
-
(2002)
J. Periodontol.
, vol.73
, pp. 726-734
-
-
Ramamurthy, N.S.1
Rifkin, B.R.2
Greenwald, R.A.3
-
49
-
-
0034655243
-
IL-9 protects mice from Gram-negative bacterial shock: Suppression of TNF-α, IL-12, and IFN-γ, and induction of IL-10
-
GROHMANN U, VAN SNICK J, CAMPANILE F et al.: IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-α, IL-12, and IFN-γ, and induction of IL-10. J. Immunol. (2000) 164:4197-4203.
-
(2000)
J. Immunol.
, vol.164
, pp. 4197-4203
-
-
Grohmann, U.1
Van Snick, J.2
Campanile, F.3
-
50
-
-
0033520477
-
Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9
-
DEMOULIN JB, VAN ROOST E, STEVENS M, GRONER B, RENAULD JC: Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9. J. Biol. Chem. (1999) 274:25855-25861.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 25855-25861
-
-
Demoulin, J.B.1
Van Roost, E.2
Stevens, M.3
Groner, B.4
Renauld, J.C.5
-
52
-
-
0038583636
-
Immunomodulating effects of 3-thia fatty acids in activated peripheral blood mononuclear cells
-
AUKRUST P, WERGEDAHL H, MULLER F et al.: Immunomodulating effects of 3-thia fatty acids in activated peripheral blood mononuclear cells. Eur. J. Clin. Invest. (2003) 33:426-433.
-
(2003)
Eur. J. Clin. Invest.
, vol.33
, pp. 426-433
-
-
Aukrust, P.1
Wergedahl, H.2
Muller, F.3
-
53
-
-
0036371311
-
Fenofibrate, a peroxisome proliferator-activated receptor α activator, suppresses experimental autoimmune myocarditis by stimulating the interleukin-10 pathway in rats
-
MARUYAMA S, KATO K, KODAMA M et al.: Fenofibrate, a peroxisome proliferator-activated receptor α activator, suppresses experimental autoimmune myocarditis by stimulating the interleukin-10 pathway in rats. J. Atheroscler. Thromb. (2002) 9:87-92.
-
(2002)
J. Atheroscler. Thromb.
, vol.9
, pp. 87-92
-
-
Maruyama, S.1
Kato, K.2
Kodama, M.3
-
54
-
-
0034069673
-
Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice
-
SMITH SR, TERMINELLI C, DENHARDT G: Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice. J. Pharmacol. Exp. Ther. (2000) 293:136-150.
-
(2000)
J. Pharmacol. Exp. Ther.
, vol.293
, pp. 136-150
-
-
Smith, S.R.1
Terminelli, C.2
Denhardt, G.3
-
55
-
-
0037027945
-
SSR125329A, a high affinity a receptor ligand with potent anti-inflammatory properties
-
BOURRIE B, BRIBES E, DE NYS N et al.: SSR125329A, a high affinity a receptor ligand with potent anti-inflammatory properties. Eur. J. Pharmacol. (2002) 456:123-131.
-
(2002)
Eur. J. Pharmacol.
, vol.456
, pp. 123-131
-
-
Bourrie, B.1
Bribes, E.2
De Nys, N.3
-
56
-
-
0347296194
-
IL-10 mediates σ1 receptor-dependent suppression of antitumor immunity
-
ZHU LX, SHARMA S, GARDNER B et al.: IL-10 mediates σ1 receptor-dependent suppression of antitumor immunity. J. Immunol. (2003) 170:3585-3591.
-
(2003)
J. Immunol.
, vol.170
, pp. 3585-3591
-
-
Zhu, L.X.1
Sharma, S.2
Gardner, B.3
-
57
-
-
0041672287
-
Inhibition of the elicitation phase of contact hypersensitivity by thymidine dinucleotides is in part mediated by increased expression of interleukin-10 in human keratinocytes
-
CURIEL-LEWANDROWSKI C, VENNA SS, ELLER MS et al.: Inhibition of the elicitation phase of contact hypersensitivity by thymidine dinucleotides is in part mediated by increased expression of interleukin-10 in human keratinocytes. Exp. Dermatol. (2003) 12:145-152.
-
(2003)
Exp. Dermatol.
, vol.12
, pp. 145-152
-
-
Curiel-Lewandrowski, C.1
Venna, S.S.2
Eller, M.S.3
-
58
-
-
0042424789
-
Imidocarb, a potent anti-protozoan drug, up-regulates interleukin-10 production by murine macrophages
-
KATAYAMA T, HAYASHI Y, NAGAHIRA K et al.: Imidocarb, a potent anti-protozoan drug, up-regulates interleukin-10 production by murine macrophages. Biochem. Biophys. Res. Commun. (2003) 309:414-418.
-
(2003)
Biochem. Biophys. Res. Commun.
, vol.309
, pp. 414-418
-
-
Katayama, T.1
Hayashi, Y.2
Nagahira, K.3
-
60
-
-
0036205491
-
HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes: Involvement of protein kinase C-βII and -δ
-
BENNASSER Y, BAHRAOUI E: HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes: involvement of protein kinase C-βII and -δ. FASEB J. (2002) 16:546-554.
-
(2002)
FASEB J.
, vol.16
, pp. 546-554
-
-
Bennasser, Y.1
Bahraoui, E.2
-
61
-
-
0042928398
-
Anti-inflammatory effects of annexin-1: Stimulation of IL-10 release and inhibition of nitric oxide synthesis
-
FERLAZZO V, D'AGOSTINO P, MILANO S et al.: Anti-inflammatory effects of annexin-1: stimulation of IL-10 release and inhibition of nitric oxide synthesis. Int. Immunopharmacol. (2003) 3:1363-1369.
-
(2003)
Int. Immunopharmacol.
, vol.3
, pp. 1363-1369
-
-
Ferlazzo, V.1
D'agostino, P.2
Milano, S.3
-
62
-
-
0037148507
-
Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression
-
WALTERSCHEID JP, ULLRICH SE, NGHIEM DX: Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J. Exp. Med. (2002) 195:171-179.
-
(2002)
J. Exp. Med.
, vol.195
, pp. 171-179
-
-
Walterscheid, J.P.1
Ullrich, S.E.2
Nghiem, D.X.3
-
63
-
-
0036037332
-
Attenuation of LPS-induced changes in synaptic activity in rat hippocampus by Vasogen's Immune Modulation Therapy
-
NOLAN Y, MINOGUE A, VEREKER E et al.: Attenuation of LPS-induced changes in synaptic activity in rat hippocampus by Vasogen's Immune Modulation Therapy. Neuroimmunomodulation (2002) 10:40-46.
-
(2002)
Neuroimmunomodulation
, vol.10
, pp. 40-46
-
-
Nolan, Y.1
Minogue, A.2
Vereker, E.3
-
64
-
-
0033224336
-
Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus
-
ESKDALE J, KEIJSERS V, HUIZINGA T, GALLAGHER G: Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun. (1999) 1:151-155.
-
(1999)
Genes Immun.
, vol.1
, pp. 151-155
-
-
Eskdale, J.1
Keijsers, V.2
Huizinga, T.3
Gallagher, G.4
-
65
-
-
0037949473
-
Differential regulation of interleukin-10 production by genetic and environmental factors - A twin study
-
REUSS E, FIMMERS R, KRUGER A et al.: Differential regulation of interleukin-10 production by genetic and environmental factors - a twin study. Genes Immun. (2002) 3:407-413.
-
(2002)
Genes Immun.
, vol.3
, pp. 407-413
-
-
Reuss, E.1
Fimmers, R.2
Kruger, A.3
-
66
-
-
0035869289
-
Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus
-
GIBSON AW, EDBERG JC, WU J et al.: Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J. Immunol. (2001) 166:3915-3922.
-
(2001)
J. Immunol.
, vol.166
, pp. 3915-3922
-
-
Gibson, A.W.1
Edberg, J.C.2
Wu, J.3
-
67
-
-
0035123858
-
Interleukin-10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection
-
YEE LJ, TANG J, GIBSON AW et al.: Interleukin-10 polymorphisms; as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology (2001) 33:708-712.
-
(2001)
Hepatology
, vol.33
, pp. 708-712
-
-
Yee, L.J.1
Tang, J.2
Gibson, A.W.3
-
68
-
-
0036809525
-
Interleukin-1, interleukin-10 and tumour necrosis factor-α gene polymorphisms in hepatitis C virus infection: An investigation of the relationships with spontaneous viral clearance and response to α-interferon therapy
-
CONSTANTINI PK, WAWRZYNOWICZ-SYCZEWSKA M, CLARE M et al.: Interleukin-1, interleukin-10 and tumour necrosis factor-α gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to α-interferon therapy. Liver (2002) 22:404-412.
-
(2002)
Liver
, vol.22
, pp. 404-412
-
-
Constantini, P.K.1
Wawrzynowicz-Syczewska, M.2
Clare, M.3
-
69
-
-
0141889852
-
Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection
-
[Electronically published ahead of print]
-
KNAPP S, HENNIG BJ, FRODSHAM AJ et al.: Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics (2003). [Electronically published ahead of print].
-
(2003)
Immunogenetics
-
-
Knapp, S.1
Hennig, B.J.2
Frodsham, A.J.3
-
70
-
-
0242685035
-
Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis
-
WHITTINGTON HA, FREEBURN RW, GODINHO SI et al.: Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis. Genes Immun. (2003) 4:258-264.
-
(2003)
Genes Immun.
, vol.4
, pp. 258-264
-
-
Whittington, H.A.1
Freeburn, R.W.2
Godinho, S.I.3
-
71
-
-
0037973669
-
A Gly15Arg mutation in the interleukin-10 gene reduces secretion of interleukin-10 in Crohn disease
-
VAN DER LINDE K, BOOR PP, SANDKUIJL LA et al.: A Gly15Arg mutation in the interleukin-10 gene reduces secretion of interleukin-10 in Crohn disease. Scand. J. Gastroenterol. (2003) 38:611-617.
-
(2003)
Scand. J. Gastroenterol.
, vol.38
, pp. 611-617
-
-
Van Der Linde, K.1
Boor, P.P.2
Sandkuijl, L.A.3
-
72
-
-
0037114921
-
Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis
-
AWOMOYI AA, MARCHANT A, HOWSON JM et al.: Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J. Infect. Dis. (2002) 186:1808-1814.
-
(2002)
J. Infect. Dis.
, vol.186
, pp. 1808-1814
-
-
Awomoyi, A.A.1
Marchant, A.2
Howson, J.M.3
-
73
-
-
0035724986
-
Inflammatory bowel disease is associated with a novel promoter polymorphism of natural resistance-associated macrophage protein 1 (NRAMP1) gene
-
KOJIMA Y, KINOUCHI Y, TAKAHASHI S et al.: Inflammatory bowel disease is associated with a novel promoter polymorphism of natural resistance-associated macrophage protein 1 (NRAMP1) gene. Tissue Antigens (2001) 58:379-384.
-
(2001)
Tissue Antigens
, vol.58
, pp. 379-384
-
-
Kojima, Y.1
Kinouchi, Y.2
Takahashi, S.3
-
74
-
-
0028350053
-
Expression cloning and characterisation of a human IL-10 receptor
-
LIU Y, WEI SH, HO AS, DE WAAL MALEFYT R, MOORE KW: Expression cloning and characterisation of a human IL-10 receptor. J Immunol (1994) 152:1821-1829.
-
(1994)
J. Immunol.
, vol.152
, pp. 1821-1829
-
-
Liu, Y.1
Wei, S.H.2
Ho, A.S.3
De Waal Malefyt, R.4
Moore, K.W.5
-
75
-
-
0035881253
-
Up-regulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10
-
CREPALDI L, GASPERINI S, LAPINET JA et al.: Up-regulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10. J. Immunol. (2001) 167:2312-2322.
-
(2001)
J. Immunol.
, vol.167
, pp. 2312-2322
-
-
Crepaldi, L.1
Gasperini, S.2
Lapinet, J.A.3
-
76
-
-
0035892751
-
Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation
-
DING Y, QIN L, ZAMARIN D et al.: Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation. J. Immunol. (2001) 167:6884-6892.
-
(2001)
J. Immunol.
, vol.167
, pp. 6884-6892
-
-
Ding, Y.1
Qin, L.2
Zamarin, D.3
-
77
-
-
0141621073
-
Interleukin-10 induction of nitric oxide synthase expression attenuates CD40-mediated interleukin-12 synthesis in human endothelial cells
-
[Electronically published ahead of print]
-
CATTARUZZA M, SLODOWSKI W, STOJAKOVIC M, KRZESZ R, HECKER M: Interleukin-10 induction of nitric oxide synthase expression attenuates CD40-mediated interleukin-12 synthesis in human endothelial cells. J. Biol. Chem. (2003). [Electronically published ahead of print].
-
(2003)
J. Biol. Chem.
-
-
Cattaruzza, M.1
Slodowski, W.2
Stojakovic, M.3
Krzesz, R.4
Hecker, M.5
-
78
-
-
0038528224
-
Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-α production
-
GASCHE C, GRUNDTNER P, ZWIRN P et al.: Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-α production. J. Immunol. (2003) 170:5578-5582.
-
(2003)
J. Immunol.
, vol.170
, pp. 5578-5582
-
-
Gasche, C.1
Grundtner, P.2
Zwirn, P.3
-
80
-
-
0030799157
-
Identification and functional characterisation of a second chain of the interleukin-10 receptor complex
-
KOTENKO SV, KRAUSE CD, IZOTOVA LS et al.: Identification and functional characterisation of a second chain of the interleukin-10 receptor complex. EMBO J. (1997) 16:5894-5903.
-
(1997)
EMBO J.
, vol.16
, pp. 5894-5903
-
-
Kotenko, S.V.1
Krause, C.D.2
Izotova, L.S.3
-
81
-
-
0033034365
-
H1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
-
H1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity (1999) 10:39-49.
-
(1999)
Immunity
, vol.10
, pp. 39-49
-
-
Takeda, K.1
Clausen, B.E.2
Kaisho, T.3
-
82
-
-
0033523019
-
Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action
-
RILEY JK, TAKEDA K, AKIRA S, SCHREIBER RD: Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J. Biol. Chem. (1999) 274:16513-16521.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 16513-16521
-
-
Riley, J.K.1
Takeda, K.2
Akira, S.3
Schreiber, R.D.4
-
83
-
-
0037799912
-
Toll-like receptor-dependent production of IL-12p4O causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice
-
KOBAYASHI M, KWEON MN, KUWATA H et al.: Toll-like receptor-dependent production of IL-12p4O causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J. Clin. Invest. (2003) 111:1297-1308.
-
(2003)
J. Clin. Invest.
, vol.111
, pp. 1297-1308
-
-
Kobayashi, M.1
Kweon, M.N.2
Kuwata, H.3
-
84
-
-
0036721716
-
Shaping gene expression in activated and resting primary macrophages by IL-10
-
LANG R, PATEL D, MORRIS JJ, RUTSCHMAN RL, MURRAY PJ: Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. (2002) 169:2253-2263.
-
(2002)
J. Immunol.
, vol.169
, pp. 2253-2263
-
-
Lang, R.1
Patel, D.2
Morris, J.J.3
Rutschman, R.L.4
Murray, P.J.5
-
85
-
-
0037310860
-
Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses
-
DING Y, CHEN D, TARCSAFALVI A et al.: Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses. J. Immunol. (2003) 170:1383-1391.
-
(2003)
J. Immunol.
, vol.170
, pp. 1383-1391
-
-
Ding, Y.1
Chen, D.2
Tarcsafalvi, A.3
-
86
-
-
0037097509
-
Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation
-
BERLATO C, CASSATELLA MA, KINJYO I et al.: Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J. Immunol. (2002) 168:6404-6411.
-
(2002)
J. Immunol.
, vol.168
, pp. 6404-6411
-
-
Berlato, C.1
Cassatella, M.A.2
Kinjyo, I.3
-
87
-
-
0037443661
-
Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3
-
NIEMAND C, NIMMESGERN A, HAAN S et al.: Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J. Immunol. (2003) 170:3263-3272.
-
(2003)
J. Immunol.
, vol.170
, pp. 3263-3272
-
-
Niemand, C.1
Nimmesgern, A.2
Haan, S.3
-
88
-
-
0037600741
-
IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages
-
YASUKAWA H, OHISHI M, MORI H et al.: IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. (2003) 4:551-556.
-
(2003)
Nat. Immunol.
, vol.4
, pp. 551-556
-
-
Yasukawa, H.1
Ohishi, M.2
Mori, H.3
-
89
-
-
0033527549
-
Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding
-
SCHOTTELIUS AJ, MAYO MW, SARTOR RB, BALDWIN ASJ: Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding. J. Biol. Chem. (1999) 274:31868-31874.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 31868-31874
-
-
Schottelius, A.J.1
Mayo, M.W.2
Sartor, R.B.3
Baldwin, A.S.J.4
-
90
-
-
0037223456
-
Interleukin-10 inhibits elevated chemokine interleukin-8 and regulated on activation normal T cell expressed and secreted production in cystic fibrosis bronchial epithelial cells by targeting the IκB kinase α/β complex
-
TABARY O, MUSELET C, ESCOTTE S et al.: Interleukin-10 inhibits elevated chemokine interleukin-8 and regulated on activation normal T cell expressed and secreted production in cystic fibrosis bronchial epithelial cells by targeting the IκB kinase α/β complex. Am. J. Pathol. (2003) 162:293-302.
-
(2003)
Am. J. Pathol.
, vol.162
, pp. 293-302
-
-
Tabary, O.1
Muselet, C.2
Escotte, S.3
-
91
-
-
0036797750
-
Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor κB
-
YU Z, ZHANG W, KONE BC: Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor κB. Biochem. J. (2002) 367:97-105.
-
(2002)
Biochem. J.
, vol.367
, pp. 97-105
-
-
Yu, Z.1
Zhang, W.2
Kone, B.C.3
-
92
-
-
0242433137
-
IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-α production in macrophages
-
[Electronically published ahead of print.]
-
KUWATA H, WATANABE Y, MIYOSHI H et al.: IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-α production in macrophages. Blood (2003). [Electronically published ahead of print.]
-
(2003)
Blood
-
-
Kuwata, H.1
Watanabe, Y.2
Miyoshi, H.3
-
93
-
-
0037438590
-
Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: An anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10
-
BERREBI D, BRUSCOLI S, COHEN N et al.: Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood (2003) 101:729-738.
-
(2003)
Blood
, vol.101
, pp. 729-738
-
-
Berrebi, D.1
Bruscoli, S.2
Cohen, N.3
-
94
-
-
0035898647
-
Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology
-
KONTOYIANNIS D, KOTLYAROV A, CARBALLO E et al.: Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J. (2001) 20:3760-3770.
-
(2001)
EMBO J.
, vol.20
, pp. 3760-3770
-
-
Kontoyiannis, D.1
Kotlyarov, A.2
Carballo, E.3
-
95
-
-
0037093989
-
Evidence for a dual mechanism for IL-10 suppression of TNF-α production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-κB in primary human macrophages
-
DENYS A, UDALOVA IA, SMITH C et al.: Evidence for a dual mechanism for IL-10 suppression of TNF-α production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-κB in primary human macrophages. J. Immunol. (2002) 168:4837-4845.
-
(2002)
J. Immunol.
, vol.168
, pp. 4837-4845
-
-
Denys, A.1
Udalova, I.A.2
Smith, C.3
-
96
-
-
0036127426
-
Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice
-
LEE TS, CHAU LY: Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. (2002) 8:240-246.
-
(2002)
Nat. Med.
, vol.8
, pp. 240-246
-
-
Lee, T.S.1
Chau, L.Y.2
-
97
-
-
0037111372
-
Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma
-
CAO S, LIU J, CHESI M et al.: Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma. J. Immunol. (2002) 169:5715-5725.
-
(2002)
J. Immunol.
, vol.169
, pp. 5715-5725
-
-
Cao, S.1
Liu, J.2
Chesi, M.3
-
100
-
-
0033910713
-
Interleukin-10 modulation of tumour necrosis factor receptors requires tyrosine kinases but not the PI 3-kinase/p70 S6 kinase pathway
-
WILLIAMS L, LALI F, CLARKE C, BRENNAN F, FOXWELL B: Interleukin-10 modulation of tumour necrosis factor receptors requires tyrosine kinases but not the PI 3-kinase/p70 S6 kinase pathway. Cytokine (2000) 12:934-943.
-
(2000)
Cytokine
, vol.12
, pp. 934-943
-
-
Williams, L.1
Lali, F.2
Clarke, C.3
Brennan, F.4
Foxwell, B.5
-
101
-
-
0043205005
-
Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC Class I binding and bind preferentially to HLA-G
-
SHIROISHI M, TSUMOTO K, AMANO K et al.: Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC Class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA (2003) 100:8856-8861.
-
(2003)
Proc. Natl. Acad. Sci. USA
, vol.100
, pp. 8856-8861
-
-
Shiroishi, M.1
Tsumoto, K.2
Amano, K.3
-
102
-
-
0030704726
-
+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
-
+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (1997) 389:737-742.
-
(1997)
Nature
, vol.389
, pp. 737-742
-
-
Groux, H.1
O'Garra, A.2
Bigler, M.3
-
104
-
-
0036687184
-
Growth and expansion of human T regulatory Type 1 cells are independent from TCR activation but require exogenous cytokines
-
BACCHETTA R, SARTIRANA C, LEVINGS MK et al.: Growth and expansion of human T regulatory Type 1 cells are independent from TCR activation but require exogenous cytokines. Eur. J. Immunol. (2002) 32:2237-2245.
-
(2002)
Eur. J. Immunol.
, vol.32
, pp. 2237-2245
-
-
Bacchetta, R.1
Sartirana, C.2
Levings, M.K.3
-
106
-
-
0035339884
-
IFN-α and IL-10 induce the differentiation of human Type 1 T regulatory cells
-
LEVINGS MK, SANGREGORIO R, GALBIATI F et al.: IFN-α and IL-10 induce the differentiation of human Type 1 T regulatory cells. J. Immunol. (2001) 166:5530-5539.
-
(2001)
J. Immunol.
, vol.166
, pp. 5530-5539
-
-
Levings, M.K.1
Sangregorio, R.2
Galbiati, F.3
-
109
-
-
0035885068
-
Differentiation of regulatory T cells 1 is induced by CD2 costimulation
-
WAKKACH A, COTTREZ F, GROUX H: Differentiation of regulatory T cells 1 is induced by CD2 costimulation. J. Immunol. (2001) 167:3107-3113.
-
(2001)
J. Immunol.
, vol.167
, pp. 3107-3113
-
-
Wakkach, A.1
Cottrez, F.2
Groux, H.3
-
110
-
-
0347895101
-
+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype
-
+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature (2003) 421:388-392.
-
(2003)
Nature
, vol.421
, pp. 388-392
-
-
Kemper, C.1
Chan, A.C.2
Green, J.M.3
-
111
-
-
0036848913
-
Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis)
-
SATOGUINA J, MEMPEL M, LARBI J et al.: Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). Microbes Infect. (2002) 4:1291-1300.
-
(2002)
Microbes Infect.
, vol.4
, pp. 1291-1300
-
-
Satoguina, J.1
Mempel, M.2
Larbi, J.3
-
112
-
-
0037097777
-
Murine Peyer's patches favor development of an IL-10-secreting, regulatory T cell population
-
JUMP RL, LEVINE AD: Murine Peyer's patches favor development of an IL-10-secreting, regulatory T cell population. J. Immunol. (2002) 168:6113-6119.
-
(2002)
J. Immunol.
, vol.168
, pp. 6113-6119
-
-
Jump, R.L.1
Levine, A.D.2
-
113
-
-
0037148511
-
Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin-10 production by dendritic cells: A novel strategy for evasion of protective T helper Type 1 responses by Bordetella pertussis
-
MCGUIRK P, MCCANN C, MILLS KH: Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin-10 production by dendritic cells: a novel strategy for evasion of protective T helper Type 1 responses by Bordetella pertussis. J. Exp. Med. (2002) 195:221-231.
-
(2002)
J. Exp. Med.
, vol.195
, pp. 221-231
-
-
Mcguirk, P.1
Mccann, C.2
Mills, K.H.3
-
114
-
-
85047691550
-
Critical role of IL-10 in the induction of low zone tolerance to contact allergens
-
[Electronically published ahead of print.]
-
MAURER M, SEIDEL-GUYENOT W, METZ M, KNOP J, STEINBRINK K: Critical role of IL-10 in the induction of low zone tolerance to contact allergens. J. Clin. Invest. (2003). [Electronically published ahead of print.]
-
(2003)
J. Clin. Invest.
-
-
Maurer, M.1
Seidel-Guyenot, W.2
Metz, M.3
Knop, J.4
Steinbrink, K.5
-
115
-
-
0037987977
-
Characterisation of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo
-
WAKKACH A, FOURNIER N, BRUN V et al.: Characterisation of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity (2003) 18:605-617.
-
(2003)
Immunity
, vol.18
, pp. 605-617
-
-
Wakkach, A.1
Fournier, N.2
Brun, V.3
-
116
-
-
0012391130
-
Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells
-
SATO K, YAMASHITA N, BABA M, MATSUYAMA T: Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood (2003) 101:3581-3589.
-
(2003)
Blood
, vol.101
, pp. 3581-3589
-
-
Sato, K.1
Yamashita, N.2
Baba, M.3
Matsuyama, T.4
-
117
-
-
0037240852
-
Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10
-
MARTIN E, O'SULLIVAN B, LOW P, THOMAS R: Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity (2003)18:155-167.
-
(2003)
Immunity
, vol.18
, pp. 155-167
-
-
Martin, E.1
O'Sullivan, B.2
Low, P.3
Thomas, R.4
-
118
-
-
0034919344
-
Dendritic cells as a tool to induce anergic and regulatory T cells
-
JONULEIT H, SCHMITT E, STEINBRINK K, ENK AH: Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. (2001) 22:394-400.
-
(2001)
Trends Immunol.
, vol.22
, pp. 394-400
-
-
Jonuleit, H.1
Schmitt, E.2
Steinbrink, K.3
Enk, A.H.4
-
119
-
-
0038792101
-
+ regulatory T cells by targeting of antigens to immature dendritic cells
-
+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood (2003) 101:4862-4869.
-
(2003)
Blood
, vol.101
, pp. 4862-4869
-
-
Mahnke, K.1
Qian, Y.2
Knop, J.3
Enk, A.H.4
-
120
-
-
0036931115
-
Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets
-
KUWANA M: Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets. Hum. Immunol. (2002) 63:1156-1163.
-
(2002)
Hum. Immunol.
, vol.63
, pp. 1156-1163
-
-
Kuwana, M.1
-
121
-
-
0034890907
-
Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen
-
AKBARI O, DEKRUYFF RH, UMETSU DT: Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. (2001) 2:725-731.
-
(2001)
Nat. Immunol.
, vol.2
, pp. 725-731
-
-
Akbari, O.1
Dekruyff, R.H.2
Umetsu, D.T.3
-
122
-
-
0036732461
-
Antigen-specific regulatory T cells develop via the ICOS/ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity
-
AKBARI O, FREEMAN GJ, MEYER EH et al.: Antigen-specific regulatory T cells develop via the ICOS/ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. (2002) 8:1024-1032.
-
(2002)
Nat. Med.
, vol.8
, pp. 1024-1032
-
-
Akbari, O.1
Freeman, G.J.2
Meyer, E.H.3
-
123
-
-
0036740602
-
ICOS and CD28 reversely regulate IL-10 on reactivation of human effector T cells with mature dendritic cells
-
WITSCH EJ, PEISER M, HUTLOFF A et al.: ICOS and CD28 reversely regulate IL-10 on reactivation of human effector T cells with mature dendritic cells. Eur. J. Immunol. (2002) 32:2680-2686.
-
(2002)
Eur. J. Immunol.
, vol.32
, pp. 2680-2686
-
-
Witsch, E.J.1
Peiser, M.2
Hutloff, A.3
-
124
-
-
0036659913
-
+ regulatory T cells in vivo in humans
-
+ regulatory T cells in vivo in humans. Blood (2002) 100:174-177.
-
(2002)
Blood
, vol.100
, pp. 174-177
-
-
Dhodapkar, M.V.1
Steinman, R.M.2
-
125
-
-
0037128654
-
Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells
-
GILLIET M, LIU YJ: Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. (2002) 195:695-704.
-
(2002)
J. Exp. Med.
, vol.195
, pp. 695-704
-
-
Gilliet, M.1
Liu, Y.J.2
-
126
-
-
0036530016
-
+ anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity
-
+ anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood (2002) 99:2468-2476.
-
(2002)
Blood
, vol.99
, pp. 2468-2476
-
-
Steinbrink, K.1
Graulich, E.2
Kubsch, S.3
Knop, J.4
Enk, A.H.5
-
127
-
-
0042467814
-
Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: Association with IL-2-and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27kip1
-
KUBSCH S, GRAULICH E, KNOP J, STEINBRINK K: Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: association with IL-2-and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27kip1. Eur. J. Immunol. (2003) 33:1988-1997.
-
(2003)
Eur. J. Immunol.
, vol.33
, pp. 1988-1997
-
-
Kubsch, S.1
Graulich, E.2
Knop, J.3
Steinbrink, K.4
-
128
-
-
0034657913
-
Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10
-
REA D, VAN KOOTEN C, VAN MEIJGAARDEN KE et al.: Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood (2000) 95:3162-3167.
-
(2000)
Blood
, vol.95
, pp. 3162-3167
-
-
Rea, D.1
Van Kooten, C.2
Van Meijgaarden, K.E.3
-
129
-
-
18544364477
-
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase
-
MUNN DH, SHARMA MD, LEE JR et al.: Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science (2002) 297:1867-1870.
-
(2002)
Science
, vol.297
, pp. 1867-1870
-
-
Munn, D.H.1
Sharma, M.D.2
Lee, J.R.3
-
130
-
-
0038278670
-
Role of interleukin-10 in the induction and function of natural and antigen-induced regulatory T cells
-
WRAITH DC: Role of interleukin-10 in the induction and function of natural and antigen-induced regulatory T cells. J. Autoimmunity (2003) 20:273-275.
-
(2003)
J. Autoimmunity
, vol.20
, pp. 273-275
-
-
Wraith, D.C.1
-
131
-
-
0037310355
-
Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo
-
SUNDSTEDT A, O'NEILL EJ, NICOLSON KS, WRAITH DC: Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J. Immunol. (2003) 170:1240-1248.
-
(2003)
J. Immunol.
, vol.170
, pp. 1240-1248
-
-
Sundstedt, A.1
O'Neill, E.J.2
Nicolson, K.S.3
Wraith, D.C.4
-
132
-
-
0036736840
-
CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation
-
OH JW, SEROOGY CM, MEYER EH et al.: CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. J. Allergy Clin. Immunol. (2002)110:460-468.
-
(2002)
J. Allergy Clin. Immunol.
, vol.110
, pp. 460-468
-
-
Oh, J.W.1
Seroogy, C.M.2
Meyer, E.H.3
-
133
-
-
0035186416
-
H3 regulatory cells
-
H3 regulatory cells. Immunol. Rev. (2001) 182:207-214.
-
(2001)
Immunol. Rev.
, vol.182
, pp. 207-214
-
-
Weiner, H.L.1
-
134
-
-
0037131969
-
+ T suppressor cell clones produce transforming growth factor-β, but not interleukin-10, and are distinct from Type 1 T regulatory cells
-
+ T suppressor cell clones produce transforming growth factor-β, but not interleukin-10, and are distinct from Type 1 T regulatory cells. J. Exp. Med. (2002) 196:1335-1346.
-
(2002)
J. Exp. Med.
, vol.196
, pp. 1335-1346
-
-
Levings, M.K.1
Sangregorio, R.2
Sartirana, C.3
-
135
-
-
0036597371
-
+ suppressor T cells: More questions than answers
-
+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. (2002) 2:389-400.
-
(2002)
Nat. Rev. Immunol.
, vol.2
, pp. 389-400
-
-
Shevach, E.M.1
-
137
-
-
0347785480
-
Control of regulatory T cell development by the transcription factor Foxp3
-
HORI S, NOMURA T, SAKAGUCHI S: Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 299:1057-1061.
-
(2003)
Science
, vol.299
, pp. 1057-1061
-
-
Hori, S.1
Nomura, T.2
Sakaguchi, S.3
-
139
-
-
0037025943
-
+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation
-
+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. (2002) 196:389-399.
-
(2002)
J. Exp. Med.
, vol.196
, pp. 389-399
-
-
Hoffmann, P.1
Ermann, J.2
Edinger, M.3
Fathman, C.G.4
Strober, S.5
-
141
-
-
0037243827
-
+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms
-
+ T(R cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. (2003) 197:111-119.
-
(2003)
J. Exp. Med.
, vol.197
, pp. 111-119
-
-
Maloy, K.J.1
Salaun, L.2
Cahill, R.3
-
143
-
-
0037099733
-
+ regulatory, contact-dependent T cells induce interleukin-1-producing, contact-independent Type 1-like regulatory T cells
-
+ regulatory, contact-dependent T cells induce interleukin-1-producing, contact-independent Type 1-like regulatory T cells. J. Exp. Med. (2002) 196:247-253.
-
(2002)
J. Exp. Med.
, vol.196
, pp. 247-253
-
-
Dieckmann, D.1
Bruett, C.H.2
Ploettner, H.3
Lutz, M.B.4
Schuler, G.5
-
145
-
-
0029070119
-
A randomised, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses
-
CHERNOFF AE, GRANOWITZ EV, SHAPIRO L et al.: A randomised, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J. Immunol. (1995) 154:5492-5499.
-
(1995)
J. Immunol.
, vol.154
, pp. 5492-5499
-
-
Chernoff, A.E.1
Granowitz, E.V.2
Shapiro, L.3
-
146
-
-
0343329759
-
A pilot trial of recombinant human interleukin-10 in kidney transplant recipients receiving OKT3 induction therapy
-
WISSING KM, MORELON E, LEGENDRE C et al.: A pilot trial of recombinant human interleukin-10 in kidney transplant recipients receiving OKT3 induction therapy. Transplantation (1997) 64:999-1006.
-
(1997)
Transplantation
, vol.64
, pp. 999-1006
-
-
Wissing, K.M.1
Morelon, E.2
Legendre, C.3
-
147
-
-
0031569474
-
Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: Effect of timing of recombinant human IL-10 administration
-
PAJKRT D, CAMOGLIO L, TIEL-VAN BUUL MC et al.: Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. J. Immunol. (1997) 158:3971-3977.
-
(1997)
J. Immunol.
, vol.158
, pp. 3971-3977
-
-
Pajkrt, D.1
Camoglio, L.2
Tiel-Van Buul, M.C.3
-
148
-
-
0030971484
-
Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia
-
PAJKRT D, VAN DER POLL T, LEVI M et al.: Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia. Blood (1997) 89:2701-2705.
-
(1997)
Blood
, vol.89
, pp. 2701-2705
-
-
Pajkrt, D.1
Van Der Poll, T.2
Levi, M.3
-
149
-
-
0034053007
-
Interleukin-10 inhibits the release of CC chemokines during human endotoxemia
-
OLSZYNA DP, PAJKRT D, LAUW FN, VAN DEVENTER SJ, VAN DER POLL T: Interleukin-10 inhibits the release of CC chemokines during human endotoxemia. J. Infect. Dis. (2000) 181:613-620.
-
(2000)
J. Infect. Dis.
, vol.181
, pp. 613-620
-
-
Olszyna, D.P.1
Pajkrt, D.2
Lauw, F.N.3
Van Deventer, S.J.4
Van Der Poll, T.5
-
150
-
-
0034284243
-
Proinflammatory effects of IL-10 during human endotoxemia
-
LAUW FN, PAJKRT D, HACK CE et al.: Proinflammatory effects of IL-10 during human endotoxemia. J. Immunol. (2000) 165:2783-2789.
-
(2000)
J. Immunol.
, vol.165
, pp. 2783-2789
-
-
Lauw, F.N.1
Pajkrt, D.2
Hack, C.E.3
-
151
-
-
0037043658
-
Inflammatory bowel disease
-
PODOLSKY DK: Inflammatory bowel disease. N. Engl. J. Med. (2002) 8:417-429.
-
(2002)
N. Engl. J. Med.
, vol.8
, pp. 417-429
-
-
Podolsky, D.K.1
-
152
-
-
0035192380
-
Inflammatory bowel disease: Lessons ftom the IL-10 gene-deficient mouse
-
MADSEN KL: Inflammatory bowel disease: lessons ftom the IL-10 gene-deficient mouse. Clin. Invest. Med. (2001) 24:250-257.
-
(2001)
Clin. Invest. Med.
, vol.24
, pp. 250-257
-
-
Madsen, K.L.1
-
153
-
-
0036743777
-
Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice
-
MAHLER M, LEITER EH: Genetic and environmental context determines the course of colitis developing in IL-10-deficient mice. Inflamm. Bowel Dis. (2002) 8:347-355.
-
(2002)
Inflamm. Bowel Dis.
, vol.8
, pp. 347-355
-
-
Mahler, M.1
Leiter, E.H.2
-
154
-
-
0035876906
-
The prevention and treatment of routine colitis using gene therapy with adenoviral vectors encoding IL-10
-
LINDSAY JO, CIESIELSKI CJ, SCHEININ T, HODGSON HJ, BRENNAN FM: The prevention and treatment of routine colitis using gene therapy with adenoviral vectors encoding IL-10. J. Immunol. (2001) 166:7625-7633.
-
(2001)
J. Immunol.
, vol.166
, pp. 7625-7633
-
-
Lindsay, J.O.1
Ciesielski, C.J.2
Scheinin, T.3
Hodgson, H.J.4
Brennan, F.M.5
-
155
-
-
0031900372
-
Role of interleukin-10 in a routine model of dextran sulfate sodium-induced colitis
-
TOMOYOSE M, MITSUYAMA K, ISHIDA H, TOYONAGA A, TANIKAWA K: Role of interleukin-10 in a routine model of dextran sulfate sodium-induced colitis. Scand. J. Gastroenterol. (1998) 33:435-430.
-
(1998)
Scand. J. Gastroenterol.
, vol.33
, pp. 430-435
-
-
Tomoyose, M.1
Mitsuyama, K.2
Ishida, H.3
Toyonaga, A.4
Tanikawa, K.5
-
156
-
-
0036953455
-
IL-10 gene therapy prevents TNBS-induced colitis
-
LINDSAY J, VAN MONTFRANS C, BRENNAN F et al.: IL-10 gene therapy prevents TNBS-induced colitis. Gene Ther. (2002) 9:1715-1721.
-
(2002)
Gene Ther.
, vol.9
, pp. 1715-1721
-
-
Lindsay, J.1
Van Montfrans, C.2
Brennan, F.3
-
157
-
-
0034463305
-
Recombinant human interleukin-10 in the treatment of patients with mild-to-moderately active Crohn's disease
-
The interleukin-10 Inflammatory Bowel Disease Cooperative Study Group
-
FEDORAK RN, GANGL A, ELSON CO et al.: Recombinant human interleukin-10 in the treatment of patients with mild-to-moderately active Crohn's disease.The interleukin-10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology (2000) 119:1473-1782.
-
(2000)
Gastroenterology
, vol.119
, pp. 1473-1782
-
-
Fedorak, R.N.1
Gangl, A.2
Elson, C.O.3
-
158
-
-
0034464148
-
Safety and efficacy of recombinant human interleukin-10 in chronic active Crohn's disease
-
Crohn's Disease IL-10 Cooperative Study Group
-
SCHREIBER S, FEDORAK RN, NIELSEN OH et al.: Safety and efficacy of recombinant human interleukin-10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology (2000) 119:1461-1472.
-
(2000)
Gastroenterology
, vol.119
, pp. 1461-1472
-
-
Schreiber, S.1
Fedorak, R.N.2
Nielsen, O.H.3
-
159
-
-
0034956334
-
Interleukin-10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
-
COLOMBEL JF, RUTGEERTS P, MALCHOW H et al.: Interleukin-10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease. Gut (2001) 49:42-46.
-
(2001)
Gut
, vol.49
, pp. 42-46
-
-
Colombel, J.F.1
Rutgeerts, P.2
Malchow, H.3
-
160
-
-
0036136867
-
Low ileal interleukin 10 concentrations are predictive of endoscopic recurrence in patients with Crohn's disease
-
MERESSE B, RUTGEERTS P, MALCHOW H et al.: Low ileal interleukin 10 concentrations are predictive of endoscopic recurrence in patients with Crohn's disease. Gut (2002) 50:25-28.
-
(2002)
Gut
, vol.50
, pp. 25-28
-
-
Meresse, B.1
Rutgeerts, P.2
Malchow, H.3
-
161
-
-
0036153395
-
Treatment of Crohn's disease with recombinant human interleukin-10 induces the proinflammatory cytokine interferon-γ
-
TILG H, VAN MONTFRANS C, VAN DEN ENDE A et al.: Treatment of Crohn's disease with recombinant human interleukin-10 induces the proinflammatory cytokine interferon-γ. Gut (2002) 50:191-195.
-
(2002)
Gut
, vol.50
, pp. 191-195
-
-
Tilg, H.1
Van Montfrans, C.2
Van Den Ende, A.3
-
162
-
-
0036636045
-
Dose-effect of interleukin-10 and its immunoregulatory role in Crohn's disease
-
SCHMIT A, CAROL M, ROBERT F et al.: Dose-effect of interleukin-10 and its immunoregulatory role in Crohn's disease. Eur. Cytokine Netw. (2002) 13:298-305.
-
(2002)
Eur. Cytokine Netw.
, vol.13
, pp. 298-305
-
-
Schmit, A.1
Carol, M.2
Robert, F.3
-
163
-
-
0000415293
-
New concepts in the treatment of rheumatoid arthritis
-
GOLDBACH-MANSKY R, LIPSKY PE: New concepts in the treatment of rheumatoid arthritis. Ann. Rev. Med. (2002) 54:197-216.
-
(2002)
Ann. Rev. Med.
, vol.54
, pp. 197-216
-
-
Goldbach-Mansky, R.1
Lipsky, P.E.2
-
165
-
-
0028813787
-
Elevated interleukin-10 levels in patients with rheumatoid arthritis
-
CUSH JJ, SPLAWSKI JB, THOMAS R et al.: Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum. (1995) 38:96-104.
-
(1995)
Arthritis Rheum.
, vol.38
, pp. 96-104
-
-
Cush, J.J.1
Splawski, J.B.2
Thomas, R.3
-
167
-
-
0034862856
-
Interleukin-10 (IL-10), not IL-4 or interferon-γ production, correlates with progression of joint destruction in rheumatoid arthritis
-
VERHOEF CM, VAN ROON JA, VIANEN ME, BIJLSMA JW, LAFEBER FP: Interleukin-10 (IL-10), not IL-4 or interferon-γ production, correlates with progression of joint destruction in rheumatoid arthritis. J. Rheumatol. (2001) 28:1960-1966.
-
(2001)
J. Rheumatol.
, vol.28
, pp. 1960-1966
-
-
Verhoef, C.M.1
Van Roon, J.A.2
Vianen, M.E.3
Bijlsma, J.W.4
Lafeber, F.P.5
-
168
-
-
0038005023
-
Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis
-
LARD LR, VAN GAALEN FA, SCHONKEREN JJ et al.: Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis. Arthritis Rheum. (2003) 48:1841-1848.
-
(2003)
Arthritis Rheum.
, vol.48
, pp. 1841-1848
-
-
Lard, L.R.1
Van Gaalen, F.A.2
Schonkeren, J.J.3
-
169
-
-
0028226993
-
Immunoregulatory role of interleukin-10 in rheumatoid arthritis
-
KATSIKIS PD, CHU CQ, BRENNAN FM, MAINI RN, FELDMANN M: Immunoregulatory role of interleukin-10 in rheumatoid arthritis. J. Exp. Med. (1994) 179:1517-1527.
-
(1994)
J. Exp. Med.
, vol.179
, pp. 1517-1527
-
-
Katsikis, P.D.1
Chu, C.Q.2
Brennan, F.M.3
Maini, R.N.4
Feldmann, M.5
-
170
-
-
0036484325
-
The molecular pathogenesis of collagen-induced arthritis in mice - A model for rheumatoid arthritis
-
HOLMDAHL R, BOCKERMANN R, BACKLUND J, YAMADA H: The molecular pathogenesis of collagen-induced arthritis in mice - a model for rheumatoid arthritis. Ageing Res. Rev. (2002) 1:135-147.
-
(2002)
Ageing Res. Rev.
, vol.1
, pp. 135-147
-
-
Holmdahl, R.1
Bockermann, R.2
Backlund, J.3
Yamada, H.4
-
171
-
-
0029959940
-
Interleukin-10 inhibition of the progression of established collagen-induced arthritis
-
WALMSLEY M, KATSIKIS PD, ABNEY E et al.: Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum. (1996) 39:495-503.
-
(1996)
Arthritis Rheum.
, vol.39
, pp. 495-503
-
-
Walmsley, M.1
Katsikis, P.D.2
Abney, E.3
-
172
-
-
0031059255
-
Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction
-
JOOSTEN LA, LUBBERTS E, DUREZ P et al.: Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. (1997) 40:249-260.
-
(1997)
Arthritis Rheum.
, vol.40
, pp. 249-260
-
-
Joosten, L.A.1
Lubberts, E.2
Durez, P.3
-
173
-
-
0035873071
-
Murine IL-10 gene transfer inhibits established collagen-induced arthritis and reduces adenovirus-mediated inflammatory responses in mouseliver
-
QUATTROCCHI E, DALLMAN MJ, DHILLON AP et al.: Murine IL-10 gene transfer inhibits established collagen-induced arthritis and reduces adenovirus-mediated inflammatory responses in mouseliver. J. Immunol. (2001) 166:5970-5978.
-
(2001)
J. Immunol.
, vol.166
, pp. 5970-5978
-
-
Quattrocchi, E.1
Dallman, M.J.2
Dhillon, A.P.3
-
174
-
-
0037791929
-
Efficacy of interleukin-10 gene electrotransfer into skeletal muscle in mice with collagen-induced arthritis
-
SAIDENBERG-KERMANAC'H N, BESSIS N, DELEUZE V et al.: Efficacy of interleukin-10 gene electrotransfer into skeletal muscle in mice with collagen-induced arthritis. J. Gene Med. (2003) 5:164-171.
-
(2003)
J. Gene Med.
, vol.5
, pp. 164-171
-
-
Saidenberg-Kermanac'h, N.1
Bessis, N.2
Deleuze, V.3
-
175
-
-
0035687259
-
Absence of endogeneous interleukin-10 enhances the evolution of murine Type-II collagen-induced arthritis
-
CUZZOCREA S, MAZZON E, DUGO L et al.: Absence of endogeneous interleukin-10 enhances the evolution of murine Type-II collagen-induced arthritis. Eur. Cytokine Netw. (2001) 12:568-580.
-
(2001)
Eur. Cytokine Netw.
, vol.12
, pp. 568-580
-
-
Cuzzocrea, S.1
Mazzon, E.2
Dugo, L.3
-
176
-
-
0141733605
-
Collagen-induced arthritis is exacerbated in IL-10-deficient mice
-
FINNEGAN A, KAPLAN CD, CAO Y et al.: Collagen-induced arthritis is exacerbated in IL-10-deficient mice. Arthritis Res. Ther. (2003) 5:R18-R24.
-
(2003)
Arthritis Res. Ther.
, vol.5
-
-
Finnegan, A.1
Kaplan, C.D.2
Cao, Y.3
-
177
-
-
0000428990
-
rHuIL-10 in subjects with active rheumatoid arthritis (RA): A Phase I and cytokine response study
-
MAINI RN, PAULUS H, BREEDVELD FC, AL E: rHuIL-10 in subjects with active rheumatoid arthritis (RA): a Phase I and cytokine response study. Arthritis Rheum. (1997) 40:S224.
-
(1997)
Arthritis Rheum.
, vol.40
-
-
Maini, R.N.1
Paulus, H.2
Breedveld, F.C.3
Al, E.4
-
178
-
-
12444266884
-
Interleukin-10 treatment of patients with rheumatoid arthritis enhances Fcγ receptor expression on monocytes and responsiveness to immune complex stimulation
-
VAN ROON J, WIJNGAARDEN S, LAFEBER FP et al.: Interleukin-10 treatment of patients with rheumatoid arthritis enhances Fcγ receptor expression on monocytes and responsiveness to immune complex stimulation. J. Rheumatol. (2003) 30:648-651.
-
(2003)
J. Rheumatol.
, vol.30
, pp. 648-651
-
-
Van Roon, J.1
Wijngaarden, S.2
Lafeber, F.P.3
-
179
-
-
0035094920
-
Stimulatory and inhibitory signals originating from the macrophage Fcγ receptors
-
GERBER JS, MOSSER DM: Stimulatory and inhibitory signals originating from the macrophage Fcγ receptors. Microbes Infect. (2001) 3:131-139.
-
(2001)
Microbes Infect.
, vol.3
, pp. 131-139
-
-
Gerber, J.S.1
Mosser, D.M.2
-
180
-
-
0037606153
-
Inhibition of interleukin-10 signaling after Fc receptor ligation and during rheumatoid arthritis
-
JI JD, TASSIULAS I, PARK-MIN KH et al.: Inhibition of interleukin-10 signaling after Fc receptor ligation and during rheumatoid arthritis. J. Exp. Med. (2003) 197:1573-1583.
-
(2003)
J. Exp. Med.
, vol.197
, pp. 1573-1583
-
-
Ji, J.D.1
Tassiulas, I.2
Park-Min, K.H.3
-
182
-
-
0042278688
-
Fcγ receptor expression levels on monocytes are elevated in rheumatoid arthritis patients with high erythrocyte sedimentation rate who do not use anti-rheumatic drugs
-
WIJNGAARDEN S, VAN ROON JA, BIJSMA JW, VAN DE VANKEL JG, LAFEBER FP: Fcγ receptor expression levels on monocytes are elevated in rheumatoid arthritis patients with high erythrocyte sedimentation rate who do not use anti-rheumatic drugs. Rheumatology (2003) 42:681-688.
-
(2003)
Rheumatology
, vol.42
, pp. 681-688
-
-
Wijngaarden, S.1
Van Roon, J.A.2
Bijsma, J.W.3
Van De Vankel, J.G.4
Lafeber, F.P.5
-
183
-
-
0002492007
-
RhuIL-10 (Tenovil) plus methotrexate in active rheumatoid arthritis (RA): A Phase I/II study
-
WEINBLATT ME, AL E: RhuIL-10 (Tenovil) plus methotrexate in active rheumatoid arthritis (RA): a Phase I/II study. Arthritis Rheum. (1999) 42:S170.
-
(1999)
Arthritis Rheum.
, vol.42
-
-
Weinblatt, M.E.1
Al, E.2
-
184
-
-
0035987537
-
Advances in the treatment of rheumatoid arthritis: Old versus new therapies
-
SARAVANAN V, HAMILTON J: Advances in the treatment of rheumatoid arthritis: old versus new therapies. Expert Opin. Pharmacother. (2002) 3:845-856.
-
(2002)
Expert Opin. Pharmacother.
, vol.3
, pp. 845-856
-
-
Saravanan, V.1
Hamilton, J.2
-
186
-
-
0036688668
-
Decreased IL-10 production by psoriatic peripheral blood mononuclear cells stimulated with streptococcal superantigen
-
AIBA S, UDDIN Z, NAKAGAWA S et al.: Decreased IL-10 production by psoriatic peripheral blood mononuclear cells stimulated with streptococcal superantigen. Exp. Dermatol. (2002) 11:337-343.
-
(2002)
Exp. Dermatol.
, vol.11
, pp. 337-343
-
-
Aiba, S.1
Uddin, Z.2
Nakagawa, S.3
-
187
-
-
0035113406
-
Response of psoriasis to interleukin-10 is associated with suppression of cutaneous Type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation
-
REICH K, GARBE C, BLASCHKE V et al.: Response of psoriasis to interleukin-10 is associated with suppression of cutaneous Type 1 inflammation, downregulation of the epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation. J. Invest. Dermatol. (2001) 116:319-329.
-
(2001)
J. Invest. Dermatol.
, vol.116
, pp. 319-329
-
-
Reich, K.1
Garbe, C.2
Blaschke, V.3
-
188
-
-
0012948856
-
Effects of systemic interleukin-10 therapy on psoriatic skin lesions: Histologic, immunohistologic, and molecular biology findings
-
ASADULLAH K, FRIEDRICH M, HANNEKEN S et al.: Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings. J. Invest. Dermatol. (2001) 116:721-727.
-
(2001)
J. Invest. Dermatol.
, vol.116
, pp. 721-727
-
-
Asadullah, K.1
Friedrich, M.2
Hanneken, S.3
-
189
-
-
0035478652
-
IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis
-
MCINNES IB, ILLEI GG, DANNING CL et al.: IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis. J. Immunol. (2001) 167:4075-4082.
-
(2001)
J. Immunol.
, vol.167
, pp. 4075-4082
-
-
Mcinnes, I.B.1
Illei, G.G.2
Danning, C.L.3
-
190
-
-
0036224092
-
Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in psoriasis
-
FRIEDRICH M, DOCKE WD, KLEIN A et al.: Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in psoriasis. J. Invest. Dermatol. (2002) 118:672-677.
-
(2002)
J. Invest. Dermatol.
, vol.118
, pp. 672-677
-
-
Friedrich, M.1
Docke, W.D.2
Klein, A.3
-
191
-
-
0036792808
-
Clinical and immunologic assessment of patients with psoriasis in a randomised, double-blind, placebo-controlled trial using recombinant human interleukin-10
-
KIMBALL AB, KAWAMURA T, TEJURA K et al.: Clinical and immunologic assessment of patients with psoriasis in a randomised, double-blind, placebo-controlled trial using recombinant human interleukin-10. Arch. Dermatol. (2002) 138:1341-1346.
-
(2002)
Arch. Dermatol.
, vol.138
, pp. 1341-1346
-
-
Kimball, A.B.1
Kawamura, T.2
Tejura, K.3
-
192
-
-
0242685170
-
IL-10 promoter polymorphisms influence disease severity and course in psoriasis
-
KINGO K, KOKS S, SILM H, VASAR E: IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes Immun. (2003) 4:455-457.
-
(2003)
Genes Immun.
, vol.4
, pp. 455-457
-
-
Kingo, K.1
Koks, S.2
Silm, H.3
Vasar, E.4
-
193
-
-
0036351191
-
Human interleukin-10 gene therapy decreases the severity and mortality of lethal pancreatitis in rats
-
ZOU WG, WANG DS, LANG MF et al.: Human interleukin-10 gene therapy decreases the severity and mortality of lethal pancreatitis in rats. J. Surg. Res. (2002) 103:121-126.
-
(2002)
J. Surg. Res.
, vol.103
, pp. 121-126
-
-
Zou, W.G.1
Wang, D.S.2
Lang, M.F.3
-
195
-
-
0037271162
-
New frontiers in the pharmacological prevention of post-ERCP pancreatitis: The cytokines
-
DEMOLS A, DEVIERE J: New frontiers in the pharmacological prevention of post-ERCP pancreatitis: the cytokines. JOP (2003) 4:49-57.
-
(2003)
JOP
, vol.4
, pp. 49-57
-
-
Demols, A.1
Deviere, J.2
-
196
-
-
0031769883
-
Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis
-
THOMPSON K, MALTBY J, FALLOWFIELD J et al.: Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis. Hepatology (1998) 28:1597-1606.
-
(1998)
Hepatology
, vol.28
, pp. 1597-1606
-
-
Thompson, K.1
Maltby, J.2
Fallowfield, J.3
-
198
-
-
0034022483
-
Interleukin-10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon non-responders
-
NELSON DR, LAUWERS GY, LAU JY, DAVIS GL: Interleukin-10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon non-responders. Gastroenterology (2000) 118:655-660.
-
(2000)
Gastroenterology
, vol.118
, pp. 655-660
-
-
Nelson, D.R.1
Lauwers, G.Y.2
Lau, J.Y.3
Davis, G.L.4
-
199
-
-
0037300152
-
Approaches for treatment of liver fibrosis in chronic hepatitis C
-
BEDOSSA P, PARADIS V: Approaches for treatment of liver fibrosis in chronic hepatitis C. Clin. Liver Dis. (2003) 7:195-210.
-
(2003)
Clin. Liver Dis.
, vol.7
, pp. 195-210
-
-
Bedossa, P.1
Paradis, V.2
-
200
-
-
0034121872
-
Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair
-
LIECHTY KW, KIM HB, ADZICK NS, CROMBLEHOLME TM: Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair. J. Pediatr. Surg. (2000) 35:866-872.
-
(2000)
J. Pediatr. Surg.
, vol.35
, pp. 866-872
-
-
Liechty, K.W.1
Kim, H.B.2
Adzick, N.S.3
Crombleholme, T.M.4
-
201
-
-
0032817772
-
Altered respiratory epithelial cell cytokine production in cystic fibrosis
-
BONFIELD TL, KONSTAN MW, BERGER M: Altered respiratory epithelial cell cytokine production in cystic fibrosis. J. Allergy Clin. Immunol. (1999) 104:72-78.
-
(1999)
J. Allergy Clin. Immunol.
, vol.104
, pp. 72-78
-
-
Bonfield, T.L.1
Konstan, M.W.2
Berger, M.3
-
202
-
-
0037083448
-
-/-) and IL-10 knockout mice causes increased expression and function of B7 costimulatory molecules on alveolar macrophages
-
-/-) and IL-10 knockout mice causes increased expression and function of B7 costimulatory molecules on alveolar macrophages. J. Immunol. (2002) 168:1903-1910.
-
(2002)
J. Immunol.
, vol.168
, pp. 1903-1910
-
-
Soltys, J.1
Bonfield, T.2
Chmiel, J.3
Berger, M.4
-
204
-
-
0031131886
-
A non-cytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice
-
ZHENG XX, STEELE AW, HANCOCK WW et al.: A non-cytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J. Immunol. (1997) 158:4507-4513.
-
(1997)
J. Immunol.
, vol.158
, pp. 4507-4513
-
-
Zheng, X.X.1
Steele, A.W.2
Hancock, W.W.3
-
205
-
-
0242685122
-
Recombinant rhesus macaque IL-10 fusion protein: A potential adjunct for tolerance induction strategies
-
Abstract 459
-
FORTINBERRY H, WU J, ASIEDU C et al.: Recombinant rhesus macaque IL-10 fusion protein: a potential adjunct for tolerance induction strategies. Am. J. Transplant. (2003) 3. Abstract 459.
-
(2003)
Am. J. Transplant.
, pp. 3
-
-
Fortinberry, H.1
Wu, J.2
Asiedu, C.3
-
206
-
-
0036083609
-
Pegylation: Engineering improved pharmaceuticals for enhanced therapy
-
MOLINEUX G: Pegylation: engineering improved pharmaceuticals for enhanced therapy. Cancer Treat. Rev. (2002) 28(Suppl.A):13-16.
-
(2002)
Cancer Treat. Rev.
, vol.28
, Issue.SUPPL. A
, pp. 13-16
-
-
Molineux, G.1
-
207
-
-
0038578329
-
Enteral immunotherapy in the treatment of chronic enterocolitis in interleukin-10-deficient mice
-
GLEHEN O, MITHIEUX F, TRAVERSE-GLEHEN A et al.: Enteral immunotherapy in the treatment of chronic enterocolitis in interleukin-10-deficient mice. Hepatogastroenterology (2003) 50:670-675.
-
(2003)
Hepatogastroenterology
, vol.50
, pp. 670-675
-
-
Glehen, O.1
Mithieux, F.2
Traverse-Glehen, A.3
-
208
-
-
0037369649
-
Local delivery of adenoviral vectors encoding murine interleukin-10 induces colonic interleukin 10 production and is therapeutic for murine colitis
-
LINDSAY JO, CIESIELSKI CJ, SCHEININ T, BRENNAN FM, HODGSON HJ: Local delivery of adenoviral vectors encoding murine interleukin-10 induces colonic interleukin 10 production and is therapeutic for murine colitis. Gut (2003) 52:363-369.
-
(2003)
Gut
, vol.52
, pp. 363-369
-
-
Lindsay, J.O.1
Ciesielski, C.J.2
Scheinin, T.3
Brennan, F.M.4
Hodgson, H.J.5
-
209
-
-
0037255898
-
Biodegradable microspheres targeting mucosal immune-regulating cells: New approach for treatment of inflammatory bowel disease
-
NAKASE H, OKAZAKI K, TABATA Y, CHIBA T: Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease. J. Gastroenterol. (2003) 38:59-62.
-
(2003)
J. Gastroenterol.
, vol.38
, pp. 59-62
-
-
Nakase, H.1
Okazaki, K.2
Tabata, Y.3
Chiba, T.4
-
210
-
-
0036893171
-
Prevention of colitis by interleukin-10-transduced T lymphocytes in the SCID mice transfer model
-
VAN MONTFRANS C, RODRIGUEZ PENA MS, PRONK I et al.: Prevention of colitis by interleukin-10-transduced T lymphocytes in the SCID mice transfer model. Gastroenterology (2002) 123:1865-1876.
-
(2002)
Gastroenterology
, vol.123
, pp. 1865-1876
-
-
Van Montfrans, C.1
Rodriguez Pena, M.S.2
Pronk, I.3
-
211
-
-
0036892993
-
Generation of regulatory gut-homing human T lymphocytes using ex vivo interleukin-10 gene transfer
-
VAN MONTFRANS C, HOOIJBERG E, RODRIGUEZ PENA MS et al.: Generation of regulatory gut-homing human T lymphocytes using ex vivo interleukin-10 gene transfer. Gastroenterology (2002) 123:1877-1888.
-
(2002)
Gastroenterology
, vol.123
, pp. 1877-1888
-
-
Van Montfrans, C.1
Hooijberg, E.2
Rodriguez Pena, M.S.3
-
212
-
-
0034714188
-
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
-
STEIDLER L, HANS W, SCHOTTE L et al.: Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science (2000) 289:1352-1355.
-
(2000)
Science
, vol.289
, pp. 1352-1355
-
-
Steidler, L.1
Hans, W.2
Schotte, L.3
-
213
-
-
0037820426
-
Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin-10
-
STEIDLER L, NEIRYNCK S, HUYGHEBAERT N et al.: Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin-10. Nat. Biotechnol. (2003) 21:785-789.
-
(2003)
Nat. Biotechnol.
, vol.21
, pp. 785-789
-
-
Steidler, L.1
Neirynck, S.2
Huyghebaert, N.3
-
215
-
-
0036146962
-
Decreased lamina propria effector cell responsiveness to interleukin-10 in ileal Crohn's disease
-
COLPAERT S, VANSTRAELEN K, LIU Z et al.: Decreased lamina propria effector cell responsiveness to interleukin-10 in ileal Crohn's disease. Clin. Immunol. (2002) 102:68-76.
-
(2002)
Clin. Immunol.
, vol.102
, pp. 68-76
-
-
Colpaert, S.1
Vanstraelen, K.2
Liu, Z.3
-
217
-
-
0033559906
-
Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws
-
WHALEN JD, LECHMAN EL, CARLOS CA et al.: Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J. Immunol. (1999) 162:3625-3632.
-
(1999)
J. Immunol.
, vol.162
, pp. 3625-3632
-
-
Whalen, J.D.1
Lechman, E.L.2
Carlos, C.A.3
-
218
-
-
0034066110
-
Intra-articular IL-10 gene transfer regulates the expression of collagen-induced arthritis (CIA) in the knee and ipsilateral paw
-
LUBBERTS E, JOOSTEN LA, VAN DEN BERSSELAAR L et al.: Intra-articular IL-10 gene transfer regulates the expression of collagen-induced arthritis (CIA) in the knee and ipsilateral paw. Clin. Exp. Immunol. (2000) 120:375-383.
-
(2000)
Clin. Exp. Immunol.
, vol.120
, pp. 375-383
-
-
Lubberts, E.1
Joosten, L.A.2
Van Den Bersselaar, L.3
-
219
-
-
0036257149
-
Endogenous regulation of a therapeutic transgene restores homeostasis in arthritic joints
-
MIAGKOV AV, VARLEY AW, MUNFORD RS, MAKAROV SS: Endogenous regulation of a therapeutic transgene restores homeostasis in arthritic joints. J. Clin. Invest. (2002) 109:1223-1229.
-
(2002)
J. Clin. Invest.
, vol.109
, pp. 1223-1229
-
-
Miagkov, A.V.1
Varley, A.W.2
Munford, R.S.3
Makarov, S.S.4
-
220
-
-
0034669972
-
Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen
-
SETOGUCHI K, MISAKI Y, ARAKI Y et al.: Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen. J. Immunol. (2000) 165:5980-5986.
-
(2000)
J. Immunol.
, vol.165
, pp. 5980-5986
-
-
Setoguchi, K.1
Misaki, Y.2
Araki, Y.3
-
221
-
-
0037450740
-
Prevention of arthritis by interleukin-10-producing B cells
-
MAURI C, GRAY D, MUSHTAQ N, LONDEI M: Prevention of arthritis by interleukin-10-producing B cells. J. Exp. Med. (2003) 197:489-501.
-
(2003)
J. Exp. Med.
, vol.197
, pp. 489-501
-
-
Mauri, C.1
Gray, D.2
Mushtaq, N.3
Londei, M.4
-
223
-
-
0036075464
-
Pharmacodynamic interaction of recombinant human interleukin-10 and prednisolone using in vitro whole blood lymphocyte proliferation
-
CHAKRABORTY A, JUSKO WJ: Pharmacodynamic interaction of recombinant human interleukin-10 and prednisolone using in vitro whole blood lymphocyte proliferation. J. Pharm. Sci. (2002) 91:1334-1342.
-
(2002)
J. Pharm. Sci.
, vol.91
, pp. 1334-1342
-
-
Chakraborty, A.1
Jusko, W.J.2
-
224
-
-
0038363534
-
IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy
-
JUTEL M, AKDIS M, BUDAK F et al.: IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. (2003) 33:1205-1214.
-
(2003)
Eur. J. Immunol.
, vol.33
, pp. 1205-1214
-
-
Jutel, M.1
Akdis, M.2
Budak, F.3
-
225
-
-
0034141551
-
Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer
-
KIM KN, WATANABE S, MA Y et al.: Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer. J. Immunol. (2000) 164:1576-1581.
-
(2000)
J. Immunol.
, vol.164
, pp. 1576-1581
-
-
Kim, K.N.1
Watanabe, S.2
Ma, Y.3
-
226
-
-
18744405989
-
Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway
-
NEUMANN E, JUDEX M, KULLMANN F et al.: Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway. Gene Ther. (2002) 9:1508-1519.
-
(2002)
Gene Ther.
, vol.9
, pp. 1508-1519
-
-
Neumann, E.1
Judex, M.2
Kullmann, F.3
-
227
-
-
0034632428
-
Transfer of interleukin-4 and interleukin-10 in patients with severe inflammatory bowel disease of the rectum
-
ROGY MA, BEINHAUER BG, REINISCH W, HUANG L, POKIESER P: Transfer of interleukin-4 and interleukin-10 in patients with severe inflammatory bowel disease of the rectum. Hum. Gene Ther. (2000) 11:1731-1741.
-
(2000)
Hum. Gene Ther.
, vol.11
, pp. 1731-1741
-
-
Rogy, M.A.1
Beinhauer, B.G.2
Reinisch, W.3
Huang, L.4
Pokieser, P.5
-
228
-
-
0036154617
-
Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators
-
VAN DE LOO FA, VAN DEN BERG WB: Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators. Rheum. Dis. Clin. North Am. (2002) 28:127-149.
-
(2002)
Rheum. Dis. Clin. North Am.
, vol.28
, pp. 127-149
-
-
Van, D.E.1
Loo, F.A.2
Van Den Berg, W.B.3
-
229
-
-
0037361819
-
Antigen-induced regulatory T cells in autoimmunity
-
VON HERRATH MG, HARRISON LC: Antigen-induced regulatory T cells in autoimmunity. Nat. Rev. Immunol. (2003) 3:223-232.
-
(2003)
Nat. Rev. Immunol.
, vol.3
, pp. 223-232
-
-
Von Herrath, M.G.1
Harrison, L.C.2
-
230
-
-
0037364976
-
Regulatory T cells in transplantation tolerance
-
WOOD KJ, SAKAGUCHI S: Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. (2003) 3:199-210.
-
(2003)
Nat. Rev. Immunol.
, vol.3
, pp. 199-210
-
-
Wood, K.J.1
Sakaguchi, S.2
-
232
-
-
0036883901
-
Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora
-
CONG Y, WEAVER CT, LAZENBY A, ELSON CO: Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J. Immunol. (2002) 169:6112-6119.
-
(2002)
J. Immunol.
, vol.169
, pp. 6112-6119
-
-
Cong, Y.1
Weaver, C.T.2
Lazenby, A.3
Elson, C.O.4
-
233
-
-
0035811015
-
3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo
-
3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. USA (2001) 98:6800-6805.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 6800-6805
-
-
Griffin, M.D.1
Lutz, W.2
Phan, V.A.3
-
234
-
-
0037314237
-
Activation of human T cells by FcR non-binding anti-CD3 mAb, hOKT3γ1 (Ala-Ala)
-
HEROLD KC, BURTON JB, FRANCOIS F et al.: Activation of human T cells by FcR non-binding anti-CD3 mAb, hOKT3γ1 (Ala-Ala). J. Clin. Invest. (2003) 111:409-418.
-
(2003)
J. Clin. Invest.
, vol.111
, pp. 409-418
-
-
Herold, K.C.1
Burton, J.B.2
Francois, F.3
-
235
-
-
0036695207
-
The role of interleukin-10 in autoimmune disease: Systemic lupus erythematosus (SLE) and multiple sclerosis (MS)
-
BEEBE AM, CUA DJ, DE WAAL MALEFYT R: The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev. (2002) 13:403-412.
-
(2002)
Cytokine Growth Factor Rev.
, vol.13
, pp. 403-412
-
-
Beebe, A.M.1
Cua, D.J.2
De Waal Malefyt, R.3
-
236
-
-
19044375882
-
Association tests with systemic lupus erythematosus (SLE) of IL-10 markers indicate a direct involvement of a CA repeat in the 5′ regulatory region
-
D'ALFONSO S, GIORDANO M, MELLAI M et al.: Association tests with systemic lupus erythematosus (SLE) of IL-10 markers indicate a direct involvement of a CA repeat in the 5′ regulatory region. Genes Immun. (2002) 3:454-463.
-
(2002)
Genes Immun.
, vol.3
, pp. 454-463
-
-
D'alfonso, S.1
Giordano, M.2
Mellai, M.3
-
237
-
-
0037214074
-
Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcγRII dependent mechanism: Implications for a possible vicious cycle maintaining B cell hyperactivity in SLE
-
RONNELID J, TEJDE A, MATHSSON L, NILSSON-EKDAHL K, NILSSON B: Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcγRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE. Ann. Rheum. Dis. (2003) 62:37-42.
-
(2003)
Ann. Rheum. Dis.
, vol.62
, pp. 37-42
-
-
Ronnelid, J.1
Tejde, A.2
Mathsson, L.3
Nilsson-Ekdahl, K.4
Nilsson, B.5
-
238
-
-
0033883903
-
Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus
-
LLORENTE L, RICHAUD-PATIN Y, GARCIA-PADILLA C et al.: Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum. (2000) 43:1790-1800.
-
(2000)
Arthritis Rheum.
, vol.43
, pp. 1790-1800
-
-
Llorente, L.1
Richaud-Patin, Y.2
Garcia-Padilla, C.3
-
239
-
-
0034039608
-
Increased serum levels of interleukin 10 in Sjogren's syndrome; correlation with increased IgG1
-
PERRIER S, SERRE AF, DUBOST JJ et al.: Increased serum levels of interleukin 10 in Sjogren's syndrome; correlation with increased IgG1. J. Rheumatol. (2000) 27:935-939.
-
(2000)
J. Rheumatol.
, vol.27
, pp. 935-939
-
-
Perrier, S.1
Serre, A.F.2
Dubost, J.J.3
-
240
-
-
0036733465
-
The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjogren's syndrome
-
FONT J, GARCIA-CARRASCO M, RAMOS-CASALS M et al.: The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjogren's syndrome. Rheumatology (2002) 41:1025-1030.
-
(2002)
Rheumatology
, vol.41
, pp. 1025-1030
-
-
Font, J.1
Garcia-Carrasco, M.2
Ramos-Casals, M.3
-
241
-
-
0036735318
-
Interleukin 10 (IL-10) influences autoimmune response in primary Sjogren's syndrome and is linked to IL-10 gene polymorphism
-
ANAYA JM, CORREA PA, HERRERA M, ESKDALE J, GALLAGHER G: Interleukin 10 (IL-10) influences autoimmune response in primary Sjogren's syndrome and is linked to IL-10 gene polymorphism. J. Rheumatol. (2002) 29:1874-1876.
-
(2002)
J. Rheumatol.
, vol.29
, pp. 1874-1876
-
-
Anaya, J.M.1
Correa, P.A.2
Herrera, M.3
Eskdale, J.4
Gallagher, G.5
-
242
-
-
0036645536
-
Activation and differentiation of autoreactive B-1 cells by interleukin-10 induce autoimmune haemolytic anaemia in Fas-deficient antierythrocyte immunoglobulin transgenic mice
-
WATANABE N, IKUTA K, NISITANI S, CHIBA T, HONJO T: Activation and differentiation of autoreactive B-1 cells by interleukin-10 induce autoimmune haemolytic anaemia in Fas-deficient antierythrocyte immunoglobulin transgenic mice. J. Exp. Med. (2002) 196:141-146.
-
(2002)
J. Exp. Med.
, vol.196
, pp. 141-146
-
-
Watanabe, N.1
Ikuta, K.2
Nisitani, S.3
Chiba, T.4
Honjo, T.5
-
243
-
-
0035871827
-
Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis
-
OSTLIE NS, KARACHUNSKI PI, WANG W et al.: Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis. J. Immunol. (2001) 166:4853-4862.
-
(2001)
J. Immunol.
, vol.166
, pp. 4853-4862
-
-
Ostlie, N.S.1
Karachunski, P.I.2
Wang, W.3
-
244
-
-
0035874537
-
Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression
-
LOPATIN U, YAO X, WILLIAMS RK et al.: Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood (2001) 97:3161-3170.
-
(2001)
Blood
, vol.97
, pp. 3161-3170
-
-
Lopatin, U.1
Yao, X.2
Williams, R.K.3
-
245
-
-
0036883973
-
In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice
-
TURNER J, GONZALEZ-JUARRERO M, ELLIS DL et al.: In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J. Immunol. (2002) 169:6343-6351.
-
(2002)
J. Immunol.
, vol.169
, pp. 6343-6351
-
-
Turner, J.1
Gonzalez-Juarrero, M.2
Ellis, D.L.3
-
246
-
-
0041656392
-
Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis
-
MURRAY HW, MOREIRA AL, LU CM et al.: Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis. J. Infect. Dis. (2003) 188:458-464.
-
(2003)
J. Infect. Dis.
, vol.188
, pp. 458-464
-
-
Murray, H.W.1
Moreira, A.L.2
Lu, C.M.3
-
247
-
-
0037213614
-
The dual role of IL-10
-
MOCELLIN S, PANELLI MC, WANG E, NAGORSEN D, MARINCOLA FM: The dual role of IL-10. Trends Immunol. (2003) 24:36-43.
-
(2003)
Trends Immunol.
, vol.24
, pp. 36-43
-
-
Mocellin, S.1
Panelli, M.C.2
Wang, E.3
Nagorsen, D.4
Marincola, F.M.5
-
248
-
-
0038404925
-
Tumor-induced interleukin-10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T cell responses
-
YANG AS, LATTIME EC: Tumor-induced interleukin-10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T cell responses. Cancer Res. (2003) 63:2150-2157.
-
(2003)
Cancer Res.
, vol.63
, pp. 2150-2157
-
-
Yang, A.S.1
Lattime, E.C.2
-
250
-
-
0035160749
-
Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: Correlation with phenotypic characteristics and outcome
-
FAYAD L, KEATING MJ, REUBEN JM et al.: Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood (2001) 97:256-263.
-
(2001)
Blood
, vol.97
, pp. 256-263
-
-
Fayad, L.1
Keating, M.J.2
Reuben, J.M.3
-
252
-
-
0036176551
-
Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery
-
GALIZIA G, ORDITURA M, ROMANO C et al.: Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin. Immunol. (2002) 102:169-178.
-
(2002)
Clin. Immunol.
, vol.102
, pp. 169-178
-
-
Galizia, G.1
Orditura, M.2
Romano, C.3
-
253
-
-
0036546608
-
Expression of interleukin-10 is inversely correlated with distant metastasis of renal cell carcinoma
-
UWATOKO N, TOKUNAGA T, HATANAKA H et al.: Expression of interleukin-10 is inversely correlated with distant metastasis of renal cell carcinoma. Int. J. Oncol. (2002) 20:729-733.
-
(2002)
Int. J. Oncol.
, vol.20
, pp. 729-733
-
-
Uwatoko, N.1
Tokunaga, T.2
Hatanaka, H.3
-
254
-
-
0038792750
-
A novel IL-10 signalling mechanism regulates TIMP-1 expression in human prostate tumour cells
-
WANG M, HU Y, STEARNS ME: A novel IL-10 signalling mechanism regulates TIMP-1 expression in human prostate tumour cells. Br. J. Cancer (2003) 88:1605-1614.
-
(2003)
Br. J. Cancer
, vol.88
, pp. 1605-1614
-
-
Wang, M.1
Hu, Y.2
Stearns, M.E.3
-
255
-
-
0037339755
-
Interleukin-10 blocks matrix metalloproteinase-2 and membrane Type 1-matrix metalloproteinase synthesis in primary human prostate tumor lines
-
STEARNS ME, WANG M, HU Y, GARCIA FU, RHIM J: Interleukin-10 blocks matrix metalloproteinase-2 and membrane Type 1-matrix metalloproteinase synthesis in primary human prostate tumor lines. Clin. Cancer Res. (2003) 9:1191-1199.
-
(2003)
Clin. Cancer Res.
, vol.9
, pp. 1191-1199
-
-
Stearns, M.E.1
Wang, M.2
Hu, Y.3
Garcia, F.U.4
Rhim, J.5
-
256
-
-
0034307688
-
Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10
-
CERVENAK L, MORBIDELLI L, DONATI D et al.: Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10. Blood (2000) 96:2568-2573.
-
(2000)
Blood
, vol.96
, pp. 2568-2573
-
-
Cervenak, L.1
Morbidelli, L.2
Donati, D.3
-
257
-
-
0042014500
-
Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer
-
KOHNO T, MIZUKAMIM H, SUZUKI M et al.: Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer. Cancer Res. (2003) 63:5091-5094.
-
(2003)
Cancer Res.
, vol.63
, pp. 5091-5094
-
-
Kohno, T.1
Mizukamim, H.2
Suzuki, M.3
-
258
-
-
0036675973
-
Correlation between interleukin-10 and vascular endothelial growth factor expression in human oesophageal cancer
-
NAGATA J, KIJIMA H, HATANAKA H et al.: Correlation between interleukin-10 and vascular endothelial growth factor expression in human oesophageal cancer. Int. J. Mol. Med. (2002) 10:169-172.
-
(2002)
Int. J. Mol. Med.
, vol.10
, pp. 169-172
-
-
Nagata, J.1
Kijima, H.2
Hatanaka, H.3
-
259
-
-
0025335354
-
Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI
-
MOORE KW, VIEIRA P, FIORENTINO DF et al.: Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science (1990) 248:1230-1234.
-
(1990)
Science
, vol.248
, pp. 1230-1234
-
-
Moore, K.W.1
Vieira, P.2
Fiorentino, D.F.3
-
260
-
-
0034677006
-
A single amino acid determines the immunostimulatory activity of interleukin 10
-
DING Y, QIN L, KOTENKO SV, PESTKA S, BROMBERG JS: A single amino acid determines the immunostimulatory activity of interleukin 10. J. Exp. Med. (2000) 191:213-224.
-
(2000)
J. Exp. Med.
, vol.191
, pp. 213-224
-
-
Ding, Y.1
Qin, L.2
Kotenko, S.V.3
Pestka, S.4
Bromberg, J.S.5
-
261
-
-
0036891259
-
A comparison of the anti-inflammatory and immuno-stimulatory activities of orf virus and ovine interleukin-10
-
HAIG DM, THOMSON J, MCINNES CJ et al.: A comparison of the anti-inflammatory and immuno-stimulatory activities of orf virus and ovine interleukin-10. Virus Res. (2002) 90:303-316.
-
(2002)
Virus Res.
, vol.90
, pp. 303-316
-
-
Haig, D.M.1
Thomson, J.2
Mcinnes, C.J.3
-
262
-
-
0342905043
-
T cell stimulation upon long-term secretion of viral IL-10
-
MULLER A, RAFTERY M, SCHONRICH G: T cell stimulation upon long-term secretion of viral IL-10. Eur. J. Immunol. (1999) 29:2740-2747.
-
(1999)
Eur. J. Immunol.
, vol.29
, pp. 2740-2747
-
-
Muller, A.1
Raftery, M.2
Schonrich, G.3
-
263
-
-
0033566812
-
Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees
-
LECHMAN ER, JAFFURS D, GHIVIZZANI SC et al.: Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees. J. Immunol. (1999) 163:2202-2208.
-
(1999)
J. Immunol.
, vol.163
, pp. 2202-2208
-
-
Lechman, E.R.1
Jaffurs, D.2
Ghivizzani, S.C.3
-
264
-
-
0035879103
-
Adenoviral delivery of human and viral IL-10 in murine sepsis
-
MINTER RM, FERRY MA, MURDAY ME et al.: Adenoviral delivery of human and viral IL-10 in murine sepsis. J. Immunol. (2001) 167:1053-1059.
-
(2001)
J. Immunol.
, vol.167
, pp. 1053-1059
-
-
Minter, R.M.1
Ferry, M.A.2
Murday, M.E.3
-
265
-
-
0035793061
-
Extended lung expression and increased tissue localisation of viral IL-10 with adenoviral gene therapy
-
MINTER RM, FERRY MA, RECTENWALD JE et al.: Extended lung expression and increased tissue localisation of viral IL-10 with adenoviral gene therapy. Proc. Natl. Acad. Sci. USA (2001) 98:277-282.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 277-282
-
-
Minter, R.M.1
Ferry, M.A.2
Rectenwald, J.E.3
-
266
-
-
0034652016
-
Viral IL-10 gene transfer decreases inflammation and cell adhesion molecule expression in a rat model of venous thrombosis
-
HENKE PK, DEBRUNYE LA, STRIETER RM et al.: Viral IL-10 gene transfer decreases inflammation and cell adhesion molecule expression in a rat model of venous thrombosis. J. Immunol. (2002) 164:2131-2141.
-
(2002)
J. Immunol.
, vol.164
, pp. 2131-2141
-
-
Henke, P.K.1
Debrunye, L.A.2
Strieter, R.M.3
-
267
-
-
0037097550
-
Suppression of autoimmune diabetes by viral IL-10 gene transfer
-
YANG Z, CHEN M, WU R et al.: Suppression of autoimmune diabetes by viral IL-10 gene transfer. J. Immunol. (2002) 168:6479-6485.
-
(2002)
J. Immunol.
, vol.168
, pp. 6479-6485
-
-
Yang, Z.1
Chen, M.2
Wu, R.3
-
268
-
-
0035004982
-
H1 cell activation and prevention of autoimmune diabetes in NOD mice by local expression of viral IL-10
-
H1 cell activation and prevention of autoimmune diabetes in NOD mice by local expression of viral IL-10. Int. Immunol. (2001) 13:685-694.
-
(2001)
Int. Immunol.
, vol.13
, pp. 685-694
-
-
Kawamoto, S.1
Nitta, Y.2
Tashiro, F.3
-
270
-
-
0035872790
-
Differential effects of myeloid dendritic cells retrovirally transduced to express mammalian or viral interleukin-10 on cytotoxic T lymphocyte and natural killer cell functions and resistance to tumor growth
-
TAKAYAMA T, TAHARA H, THOMSON AW: Differential effects of myeloid dendritic cells retrovirally transduced to express mammalian or viral interleukin-10 on cytotoxic T lymphocyte and natural killer cell functions and resistance to tumor growth. Transplantation (2001) 71:1334-1340.
-
(2001)
Transplantation
, vol.71
, pp. 1334-1340
-
-
Takayama, T.1
Tahara, H.2
Thomson, A.W.3
-
271
-
-
0031667550
-
Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses
-
DEBRUYNE LA, LI Y, CHAN SY et al.: Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses. Gene Ther. (1998) 5:1079-1087.
-
(1998)
Gene Ther.
, vol.5
, pp. 1079-1087
-
-
Debruyne, L.A.1
Li, Y.2
Chan, S.Y.3
-
272
-
-
0035868464
-
Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection
-
ZUO Z, WANG C, CARPENTER D et al.: Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection. Transplantation (2001) 71:686-691.
-
(2001)
Transplantation
, vol.71
, pp. 686-691
-
-
Zuo, Z.1
Wang, C.2
Carpenter, D.3
-
274
-
-
0037115125
-
High level expression of viral interleukin-10 in cardiac allografts fails to prolong graft survival
-
ADACHI O, YAMATO E, KAWAMOTO S et al.: High level expression of viral interleukin-10 in cardiac allografts fails to prolong graft survival. Transplantation (2002) 74:1603-1608.
-
(2002)
Transplantation
, vol.74
, pp. 1603-1608
-
-
Adachi, O.1
Yamato, E.2
Kawamoto, S.3
-
275
-
-
0041743152
-
Altered cutaneous immune parameters in transgenic mice overexpressing viral IL-10 in the epidermis
-
DING W, BEISSERT S, DENG L et al.: Altered cutaneous immune parameters in transgenic mice overexpressing viral IL-10 in the epidermis. J. Clin. Invest. (2003) 111:1923-1931.
-
(2003)
J. Clin. Invest.
, vol.111
, pp. 1923-1931
-
-
Ding, W.1
Beissert, S.2
Deng, L.3
-
276
-
-
0036058131
-
High level expression and purification of the Epstein-Barr virus encoded cytokine viral interleukin-10: Efficient removal of endotoxin
-
SALEK-ARDAKANI S, STUART AD, ARRAND JE et al.: High level expression and purification of the Epstein-Barr virus encoded cytokine viral interleukin-10: efficient removal of endotoxin. Cytokine (2002) 17:1-13.
-
(2002)
Cytokine
, vol.17
, pp. 1-13
-
-
Salek-Ardakani, S.1
Stuart, A.D.2
Arrand, J.E.3
-
277
-
-
0036934980
-
Epstein-Barr virus encoded interleukin-10 inhibits HLA-Class I, ICAM-1, and B7 expression on human monocytes: Implications for immune evasion by EBV
-
SALEK-ARDAKANI S, ARRAND JR, MACKETT M: Epstein-Barr virus encoded interleukin-10 inhibits HLA-Class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV. Virology (2002) 304:342-351.
-
(2002)
Virology
, vol.304
, pp. 342-351
-
-
Salek-Ardakani, S.1
Arrand, J.R.2
Mackett, M.3
-
278
-
-
0030699236
-
Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infection
-
TANNER JE, DIAZ-MITOMA F, ROONEY CM, ALFIERI C: Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infection. J. Infect. Dis. (1997) 176:1454-1461.
-
(1997)
J. Infect. Dis.
, vol.176
, pp. 1454-1461
-
-
Tanner, J.E.1
Diaz-Mitoma, F.2
Rooney, C.M.3
Alfieri, C.4
-
279
-
-
0035076457
-
Frequent recognition of BCRF1, a late lytic cycle protein of Epstein-Barr virus, in the HLA-B*2705 context: Evidence for a TAP-independent processing
-
SAULQUIN X, BODINIER M, PEYRAT MA et al.: Frequent recognition of BCRF1, a late lytic cycle protein of Epstein-Barr virus, in the HLA-B*2705 context: evidence for a TAP-independent processing. Eur. J. Immunol. (2001) 31:708-715.
-
(2001)
Eur. J. Immunol.
, vol.31
, pp. 708-715
-
-
Saulquin, X.1
Bodinier, M.2
Peyrat, M.A.3
-
280
-
-
0037017382
-
+1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin-10
-
SAULQUIN X, SCOTET E, TRAUTMANN L et al.: +1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin-10. J. Exp. Med. (2002) 195:353-358.
-
(2002)
J. Exp. Med.
, vol.195
, pp. 353-358
-
-
Saulquin, X.1
Scotet, E.2
Trautmann, L.3
-
281
-
-
0037383748
-
A novel function for the Epstein-Barr virus transcription factor EB1/Zta: Induction of transcription of the hIL-10 gene
-
MAHOT S, SERGEANT A, DROUET E, GRUFFAT H: A novel function for the Epstein-Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene. J. Gen. Virol. (2003) 84:965-974.
-
(2003)
J. Gen. Virol.
, vol.84
, pp. 965-974
-
-
Mahot, S.1
Sergeant, A.2
Drouet, E.3
Gruffat, H.4
-
282
-
-
0034652261
-
Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)
-
KOTENKO SV, SACCANI S, IZOTOVA LS, MIROCHNITCHENKO OV, PESTKA S: Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. USA (2000) 97:1695-1700.
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 1695-1700
-
-
Kotenko, S.V.1
Saccani, S.2
Izotova, L.S.3
Mirochnitchenko, O.V.4
Pestka, S.5
-
283
-
-
0034653525
-
Primate cytomegaloviruses encode and express an IL-10-like protein
-
LOCKRIDGE KM, ZHOU SS, KRAVITZ RH et al.: Primate cytomegaloviruses encode and express an IL-10-like protein. Virology (2000) 268:272-280.
-
(2000)
Virology
, vol.268
, pp. 272-280
-
-
Lockridge, K.M.1
Zhou, S.S.2
Kravitz, R.H.3
-
284
-
-
0037047128
-
Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1
-
JONES BC, LOGSDON NJ, JOSEPHSON K et al.: Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. Proc. Natl. Acad. Sci. USA (2002) 99:9404-9409.
-
(2002)
Proc. Natl. Acad. Sci. USA
, vol.99
, pp. 9404-9409
-
-
Jones, B.C.1
Logsdon, N.J.2
Josephson, K.3
-
285
-
-
0036147258
-
Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10
-
SPENCER JV, LOCKRIDGE KM, BARRY PA et al.: Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J. Virol. (2002) 76:1285-1292.
-
(2002)
J. Virol.
, vol.76
, pp. 1285-1292
-
-
Spencer, J.V.1
Lockridge, K.M.2
Barry, P.A.3
-
286
-
-
0033834737
-
Sequence and functional analysis of a homolog of interleukin-10 encoded by the parapoxvirus orf virus
-
FLEMING SB, HAIG DM, NETTLETON P et al.: Sequence and functional analysis of a homolog of interleukin-10 encoded by the parapoxvirus orf virus. Virus Genes (2000) 21:85-95.
-
(2000)
Virus Genes
, vol.21
, pp. 85-95
-
-
Fleming, S.B.1
Haig, D.M.2
Nettleton, P.3
-
287
-
-
0036246656
-
Orf virus-encoded interleukin-10 stimulates the proliferation of murine mast cells and inhibits cytokine synthesis in murine peritoneal macrophages
-
IMLACH W, MCCAUGHAN CA, MERCER AA, HAIG D, FLEMING SB: Orf virus-encoded interleukin-10 stimulates the proliferation of murine mast cells and inhibits cytokine synthesis in murine peritoneal macrophages. J. Gen. Virol. (2002) 83:1049-1058.
-
(2002)
J. Gen. Virol.
, vol.83
, pp. 1049-1058
-
-
Imlach, W.1
Mccaughan, C.A.2
Mercer, A.A.3
Haig, D.4
Fleming, S.B.5
-
288
-
-
0038325639
-
Orf virus-encoding interleulin-10 inhibits maturation, antigen presentation and migration of murine dendritic cells
-
LATEEF Z, FLEMING S, HALLIDAY G et al.: Orf virus-encoding interleulin-10 inhibits maturation, antigen presentation and migration of murine dendritic cells. J. Gen. Virol. (2003) 84:1101-1109.
-
(2003)
J. Gen. Virol.
, vol.84
, pp. 1101-1109
-
-
Lateef, Z.1
Fleming, S.2
Halliday, G.3
|